{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":832,"total_is_capped":false,"direct_labels_cover":9,"predictions_cover":832,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"ca2496bf98f8","filters":{"venue":"The Lancet Oncology"}},"results":[{"id":"W2158681922","doi":"10.1016/s1470-2045(09)70025-7","title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","year":2009,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7801,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Ontario Institute for Cancer Research; Queen's University; Hôpital Notre-Dame; Western University; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Temozolomide; Radiation therapy; Concomitant; Internal medicine; Hazard ratio; Clinical endpoint; Oncology; Adjuvant; Cancer; Clinical trial; Surgery; Confidence interval","authors":[{"name":"Roger Stupp","is_ca":false},{"name":"Monika E. Hegi","is_ca":false},{"name":"Warren Mason","is_ca":true},{"name":"Martin J. van den Bent","is_ca":false},{"name":"Martin Taphoorn","is_ca":false},{"name":"Robert C. Janzer","is_ca":false},{"name":"Samuel K. Ludwin","is_ca":true},{"name":"Anouk Allgeier","is_ca":false},{"name":"Barbara Fisher","is_ca":true},{"name":"Karl Bélanger","is_ca":true},{"name":"Peter Hau","is_ca":false},{"name":"Alba A. Brandes","is_ca":false},{"name":"Johanna M. M. Gijtenbeek","is_ca":false},{"name":"Christine Marosi","is_ca":false},{"name":"Charles J. Vecht","is_ca":false},{"name":"Karima Mokhtari","is_ca":false},{"name":"Pieter Wesseling","is_ca":false},{"name":"S. Villà","is_ca":false},{"name":"Elizabeth A. Eisenhauer","is_ca":true},{"name":"Thierry Gorlia","is_ca":false},{"name":"Michael Weller","is_ca":false},{"name":"Denis Lacombe","is_ca":false},{"name":"J. Gregory Cairncross","is_ca":true},{"name":"René‐Olivier Mirimanoff","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02105482544595683,"gpt":0.3383414721996334,"spread":0.3172866467536766,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004076968,0.002527892,0.005350562,0.0004952691,0.0005002657,0.001596658,0.001626146,0.002057895,0.003669279],"category_scores_gemma":[0.003675116,0.0009223823,0.004714944,0.0007719201,0.001901519,0.001957721,0.0008116091,0.005524458,0.0008007418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001732774,"about_ca_system_score_gemma":0.001597611,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002388318,"about_ca_topic_score_gemma":0.004862433,"domain_scores_codex":[0.9978511,0.001374245,0.0001124866,0.0003197032,0.00009521106,0.0002472839],"domain_scores_gemma":[0.9975873,0.0009102363,0.0005417529,0.0002633347,0.00008783901,0.0006094055],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9924138,0.001097748,0.0004636676,0.000160448,0.001415219,0.0000146871,0.00002596412,0.0003300674,0.0005525629,0.00004187813,0.0002158702,0.003268123],"study_design_scores_gemma":[0.8867339,0.101299,0.006197281,0.00006220468,0.003720664,0.00005468048,0.00004837373,0.0006603046,0.0004005383,0.0003416054,0.0004429107,0.00003837718],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922475,0.004427704,0.0003675773,0.0004892552,0.0004044264,0.0005020599,0.0006866669,0.00005053058,0.0008243803],"genre_scores_gemma":[0.9942318,0.001865921,0.0005625941,0.0004246181,0.0003460275,0.0005819587,0.0007997561,0.00003034208,0.001156893],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005350562,"threshold_uncertainty_score":0.02156132,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2145280166","doi":"10.1016/s1470-2045(10)70218-7","title":"Definition and classification of cancer cachexia: an international consensus","year":2011,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":5631,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Cachexia; Consensus conference; Cancer cachexia; Cancer; Intensive care medicine; Medicine; Political science; Internal medicine","authors":[{"name":"Kenneth Fearon","is_ca":false},{"name":"Florian Strasser","is_ca":false},{"name":"Stefan D. Anker","is_ca":false},{"name":"Ingvar Bosæus","is_ca":false},{"name":"Éduardo Bruera","is_ca":false},{"name":"Robin L. Fainsinger","is_ca":true},{"name":"Aminah Jatoi","is_ca":false},{"name":"Charles L. Loprinzi","is_ca":false},{"name":"Neil Macdonald","is_ca":false},{"name":"Giovanni Mantovani","is_ca":false},{"name":"Mellar P. Davis","is_ca":false},{"name":"Maurizio Muscaritoli","is_ca":false},{"name":"Faith D. Ottery","is_ca":false},{"name":"Lukas Radbruch","is_ca":false},{"name":"Paula Ravasco","is_ca":false},{"name":"Declan Walsh","is_ca":false},{"name":"Andrew Wilcock","is_ca":false},{"name":"Stein Kaasa","is_ca":false},{"name":"Vickie E. Baracos","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5331106926091742,"gpt":0.5308219039922553,"spread":0.002288788616918946,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01175478,0.002658186,0.008540676,0.00924838,0.001140998,0.004906989,0.006006633,0.003656126,0.001878558],"category_scores_gemma":[0.009812346,0.0009586032,0.005048321,0.007842866,0.003608524,0.006180389,0.003075009,0.008123886,0.001168982],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005610576,"about_ca_system_score_gemma":0.01398897,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01116491,"about_ca_topic_score_gemma":0.01202487,"domain_scores_codex":[0.9965842,0.0006448642,0.001186943,0.0005660689,0.0008187105,0.0001992274],"domain_scores_gemma":[0.99433,0.002517672,0.0007968366,0.0001389182,0.001949653,0.000266926],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003022952,0.0001229381,0.002715757,0.04663566,0.0007975172,0.0002839879,0.0005176272,0.001036759,0.0008161219,0.01621496,0.08680451,0.843752],"study_design_scores_gemma":[0.000301459,0.0002904092,0.008711164,0.09314352,0.002935563,0.003276843,0.00150082,0.001355226,0.0008372687,0.02489346,0.8624625,0.0002918009],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002255396,0.9903167,0.001404069,0.006066867,0.001213679,0.0000396821,0.0001136942,0.00001963848,0.0006000685],"genre_scores_gemma":[0.002703414,0.984923,0.006736977,0.003560109,0.00113223,0.000101038,0.0004019037,0.00001563321,0.0004256159],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01175478,"threshold_uncertainty_score":0.06216598,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2127424726","doi":"10.1016/s1470-2045(08)70153-0","title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","year":2008,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":3195,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sarcopenic obesity; Sarcopenia; Obesity; Body mass index; Internal medicine; Geriatric oncology; Population; Hazard ratio; Cancer; Gastroenterology; Confidence interval","authors":[{"name":"Carla M. Prado","is_ca":true},{"name":"Jessica Lieffers","is_ca":true},{"name":"Linda J. McCargar","is_ca":true},{"name":"Tony Reiman","is_ca":true},{"name":"Michael B. Sawyer","is_ca":true},{"name":"Lisa Martin","is_ca":true},{"name":"Vickie E. Baracos","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09781448145996925,"gpt":0.4135071674502254,"spread":0.3156926859902562,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006734703,0.0004701611,0.0005499526,0.000956442,0.0008104928,0.001115134,0.0004384667,0.001334997,0.001438558],"category_scores_gemma":[0.002040152,0.0007699945,0.0008068141,0.001516915,0.0006430795,0.001052162,0.0006567073,0.001213779,0.0003292531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003178247,"about_ca_system_score_gemma":0.0002799696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004004496,"about_ca_topic_score_gemma":0.004182558,"domain_scores_codex":[0.9994567,0.0001705973,0.00006586742,0.0001370596,0.00008536087,0.00008448402],"domain_scores_gemma":[0.9988588,0.0001636083,0.0004119655,0.0001099361,0.0001333013,0.0003223715],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001447222,0.0000689121,0.9991251,0.00000471979,0.00006018594,0.00005342583,0.00006339618,0.000009529729,0.0001447266,0.000007039579,0.00003264535,0.0002855929],"study_design_scores_gemma":[0.00001013837,0.0001404392,0.9993174,0.00000176083,0.00003287376,0.0001909335,0.0002055103,0.00003856236,0.0000107989,0.00001056458,0.0000374585,0.000003607786],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992977,0.0001691521,0.00003667267,0.00004924406,0.000006117366,0.000007541795,0.0001674289,0.00000164282,0.0002645887],"genre_scores_gemma":[0.9995609,0.00008946274,0.0000305025,0.00004031056,0.00001527969,0.000007953289,0.0001602619,0.000001202959,0.00009417051],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004004496,"threshold_uncertainty_score":0.007962406,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2486629951","doi":"10.1016/s1470-2045(16)30206-6","title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","year":2016,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2995,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Multiple myeloma; Minimal residual disease; Medicine; Bone marrow; Myeloma protein; Clinical trial; Disease; Oncology; Monoclonal; Internal medicine; Monoclonal antibody; Immunology; Antibody","authors":[{"name":"Shaji Kumar","is_ca":false},{"name":"Bruno Paiva","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false},{"name":"Brian G.M. Durie","is_ca":false},{"name":"Ola Landgren","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Nikhil C. Munshi","is_ca":false},{"name":"Sagar Lonial","is_ca":false},{"name":"Joan Bladé","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Efstathios Kastritis","is_ca":false},{"name":"Mario Boccadoro","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Andrew Spencer","is_ca":false},{"name":"Jian Hou","is_ca":false},{"name":"Wee Joo Chng","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false},{"name":"Elena Zamagni","is_ca":false},{"name":"Kazuyuki Shimizu","is_ca":false},{"name":"Sundar Jagannath","is_ca":false},{"name":"Hans Erik Johnsen","is_ca":false},{"name":"Evangelos Terpos","is_ca":false},{"name":"Tony Reiman","is_ca":true},{"name":"Robert A. Kyle","is_ca":false},{"name":"Pieter Sonneveld","is_ca":false},{"name":"Paul G. Richardson","is_ca":false},{"name":"Philip L. McCarthy","is_ca":false},{"name":"Heinz Ludwig","is_ca":false},{"name":"Wen-Ming Chen","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Jean‐Luc Harousseau","is_ca":false},{"name":"Suzanne Lentzsch","is_ca":false},{"name":"Jens Hillengaß","is_ca":false},{"name":"Antonio Palumbo","is_ca":false},{"name":"Alberto Órfão","is_ca":false},{"name":"S. Vincent Rajkumar","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false},{"name":"Hervé Avet‐Loiseau","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1849845355372984,"gpt":0.4731506599377273,"spread":0.2881661244004289,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02035962,0.001671835,0.008345437,0.005463595,0.0008364171,0.003302782,0.004407658,0.002701049,0.003527327],"category_scores_gemma":[0.0311626,0.0007031651,0.006637072,0.003992476,0.001730304,0.001842911,0.002407068,0.004147543,0.001278413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004842759,"about_ca_system_score_gemma":0.01080067,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008423733,"about_ca_topic_score_gemma":0.01306157,"domain_scores_codex":[0.9893876,0.003857712,0.003528046,0.0004765324,0.002374928,0.0003751316],"domain_scores_gemma":[0.981818,0.01140189,0.00289162,0.0003034743,0.003216306,0.0003687209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001108975,0.000134728,0.004589734,0.1269219,0.003562734,0.0002381485,0.0004197025,0.00108509,0.0007080137,0.007693138,0.1016684,0.7518695],"study_design_scores_gemma":[0.002085608,0.0006830731,0.02539524,0.2171715,0.01410533,0.002368834,0.0006840591,0.001770611,0.001299681,0.01882618,0.715267,0.0003427727],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005837761,0.9829705,0.002838294,0.006184016,0.001356168,0.001054248,0.0009768977,0.00007742318,0.003958716],"genre_scores_gemma":[0.02745804,0.9124593,0.03521663,0.01091144,0.002228097,0.004419878,0.00461038,0.00007560513,0.002620622],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02035962,"threshold_uncertainty_score":0.1076732,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112121482","doi":"10.1016/s1470-2045(15)70076-8","title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2666,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; McGill University","funders":"National Institutes of Health; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Open label; Medicine; Nivolumab; Oncology; Chemotherapy; Internal medicine; Ipilimumab; Randomized controlled trial; Immunotherapy; Cancer","authors":[{"name":"Jeffrey S. Weber","is_ca":false},{"name":"Sandra P. D’Angelo","is_ca":false},{"name":"David R. Minor","is_ca":false},{"name":"F. Stephen Hodi","is_ca":false},{"name":"Ralf Gutzmer","is_ca":false},{"name":"Bart Neyns","is_ca":false},{"name":"Christoph Höeller","is_ca":false},{"name":"Nikhil I. Khushalani","is_ca":false},{"name":"Wilson H. Miller","is_ca":true},{"name":"Christopher D. Lao","is_ca":false},{"name":"Gerald P. Linette","is_ca":false},{"name":"L. Thomas","is_ca":false},{"name":"Paul Lorigan","is_ca":false},{"name":"Kenneth F. Grossmann","is_ca":false},{"name":"Jessica C. Hassel","is_ca":false},{"name":"Michele Maio","is_ca":false},{"name":"Mario Sznol","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false},{"name":"Peter Mohr","is_ca":false},{"name":"Bartosz Chmielowski","is_ca":false},{"name":"Alan H. Bryce","is_ca":false},{"name":"Inge Marie Svane","is_ca":false},{"name":"Jean‐Jacques Grob","is_ca":false},{"name":"Angela M. Krackhardt","is_ca":false},{"name":"Christine E. Horak","is_ca":false},{"name":"Alexandre Lambert","is_ca":false},{"name":"Arvin Yang","is_ca":false},{"name":"James Larkin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05803676378711036,"gpt":0.3752254400827541,"spread":0.3171886762956437,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001287974,0.001181378,0.002264216,0.000287398,0.0003047606,0.001052349,0.000757686,0.001575787,0.004668729],"category_scores_gemma":[0.00151519,0.0005328783,0.002323075,0.000304987,0.0009018492,0.001014309,0.0003563082,0.00318503,0.0007976077],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008749823,"about_ca_system_score_gemma":0.0007385144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001245803,"about_ca_topic_score_gemma":0.00323372,"domain_scores_codex":[0.9995334,0.000266114,0.00002098991,0.00007855015,0.00002465633,0.00007625762],"domain_scores_gemma":[0.99938,0.0002167655,0.0001159185,0.00004502973,0.00003359313,0.0002087002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9747882,0.003232023,0.0007450425,0.0006180034,0.001150378,0.00003686139,0.00005489419,0.000455368,0.001718183,0.0001138567,0.0009111848,0.01617604],"study_design_scores_gemma":[0.9433854,0.05296362,0.001582022,0.00004171962,0.0005183443,0.00002796396,0.00002767848,0.0004429325,0.0002413988,0.0001881716,0.0005666455,0.00001417169],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895294,0.004473193,0.0003984792,0.0008100087,0.0006925181,0.001541807,0.0007464513,0.00008765172,0.001720464],"genre_scores_gemma":[0.9911916,0.001974671,0.0007296998,0.001088308,0.0002739143,0.001244984,0.0007534458,0.00002094508,0.002722509],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004668729,"threshold_uncertainty_score":0.0156185,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2805592007","doi":"10.1016/s1470-2045(18)30351-6","title":"Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2536,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Merck","keywords":"Medicine; Pembrolizumab; Sorafenib; Internal medicine; Clinical endpoint; Hepatocellular carcinoma; Adverse effect; Response Evaluation Criteria in Solid Tumors; Population; Oncology; Discontinuation; Clinical trial; Phases of clinical research; Surgery; Cancer; Immunotherapy","authors":[{"name":"Andrew X. Zhu","is_ca":false},{"name":"Richard S. Finn","is_ca":false},{"name":"Julien Edeline","is_ca":false},{"name":"Stéphane Cattan","is_ca":false},{"name":"Sadahisa Ogasawara","is_ca":false},{"name":"Daniel H. Palmer","is_ca":false},{"name":"Chris Verslype","is_ca":false},{"name":"Vittorina Zagonel","is_ca":false},{"name":"Lætitia Fartoux","is_ca":false},{"name":"Arndt Vogel","is_ca":false},{"name":"Debashis Sarker","is_ca":false},{"name":"Gontran Verset","is_ca":false},{"name":"Stephen L. Chan","is_ca":false},{"name":"Jennifer J. Knox","is_ca":true},{"name":"Bruno Daniele","is_ca":false},{"name":"Andrea L. Webber","is_ca":false},{"name":"Scot Ebbinghaus","is_ca":false},{"name":"Junshui Ma","is_ca":false},{"name":"Abby B. Siegel","is_ca":false},{"name":"Ann‐Lii Cheng","is_ca":false},{"name":"Masatoshi Kudo","is_ca":false},{"name":"Angela Alistar","is_ca":false},{"name":"Jamil Asselah","is_ca":false},{"name":"Jean‐Frédéric Blanc","is_ca":false},{"name":"Ivan Borbath","is_ca":false},{"name":"Timothy Lewis Cannon","is_ca":false},{"name":"Ki Y. Chung","is_ca":false},{"name":"Allen Lee Cohn","is_ca":false},{"name":"David Cosgrove","is_ca":false},{"name":"Nevena Damjanov","is_ca":false},{"name":"Mukul Gupta","is_ca":false},{"name":"Yoshivasu Karino","is_ca":false},{"name":"Mark Karwal","is_ca":false},{"name":"Andreas Kaubisch","is_ca":false},{"name":"Robin Kate Kelley","is_ca":false},{"name":"Jena-Luc Van Laethem","is_ca":false},{"name":"Timothy Larson","is_ca":false},{"name":"James Lee","is_ca":false},{"name":"Daneng Li","is_ca":false},{"name":"Atisha Manhas","is_ca":false},{"name":"Gulam A. Manji","is_ca":false},{"name":"Kazushi Numata","is_ca":false},{"name":"Benjamin M. Parsons","is_ca":false},{"name":"Andrew Scott Paulson","is_ca":false},{"name":"Carmine Pinto","is_ca":false},{"name":"Robert A. Ramirez","is_ca":false},{"name":"Suresh Ratnam","is_ca":false},{"name":"Magnus Rizell","is_ca":false},{"name":"Olivier Rosmorduc","is_ca":false},{"name":"Yvonne H. Sada","is_ca":false},{"name":"Yutaka Sasaki","is_ca":false},{"name":"Per Stål","is_ca":false},{"name":"Simone I. Strasser","is_ca":false},{"name":"Joerg Trojan","is_ca":false},{"name":"Gina M. Vaccaro","is_ca":false},{"name":"Hans Van Vlierberghe","is_ca":false},{"name":"Alan Weiss","is_ca":false},{"name":"Karl-Heinz Weiss","is_ca":false},{"name":"Tatsuya Yamashita","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07727556601902094,"gpt":0.3280706321942589,"spread":0.2507950661752379,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001511291,0.00139486,0.002334464,0.0003159672,0.0003243759,0.001114314,0.0004754582,0.001185065,0.004731635],"category_scores_gemma":[0.001308879,0.0005465918,0.002060571,0.0003549094,0.0008036386,0.001359865,0.0004064382,0.002678124,0.000948113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00072993,"about_ca_system_score_gemma":0.0007644733,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008567562,"about_ca_topic_score_gemma":0.00177596,"domain_scores_codex":[0.9995603,0.0002249336,0.00002377635,0.00007346441,0.00002757068,0.00008988533],"domain_scores_gemma":[0.9994732,0.0001330187,0.0001214209,0.0000416205,0.0000286779,0.0002021243],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9538386,0.004447645,0.001685023,0.0009179621,0.001966775,0.00008088331,0.00007590077,0.0007010108,0.003433473,0.0001478536,0.001385393,0.0313194],"study_design_scores_gemma":[0.9233016,0.06913009,0.004327935,0.00005568074,0.0008719969,0.00008503078,0.00004201143,0.0004715607,0.0004260052,0.0002279034,0.001039505,0.00002079215],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891185,0.005578705,0.0004031599,0.001074448,0.0004009969,0.0009968645,0.0007138883,0.00008079356,0.001632569],"genre_scores_gemma":[0.9902804,0.003511319,0.0006454292,0.0008940428,0.0002663889,0.001089927,0.001193667,0.00001531314,0.002103418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004731635,"threshold_uncertainty_score":0.01582885,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3083986479","doi":"10.1016/s1470-2045(20)30445-9","title":"Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study","year":2020,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2492,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Cohort; Mesothelioma; Biomarker; Clinical endpoint; Prospective cohort study; Cancer; Progressive disease; Disease; Immunotherapy; Pathology; Clinical trial","authors":[{"name":"Aurélien Marabelle","is_ca":false},{"name":"Marwan Fakih","is_ca":false},{"name":"Juanita Lopez","is_ca":false},{"name":"Manisha H. Shah","is_ca":false},{"name":"Ronnie Shapira‐Frommer","is_ca":false},{"name":"Kazuhiko Nakagawa","is_ca":false},{"name":"Hyun Cheol Chung","is_ca":false},{"name":"Hedy L. Kindler","is_ca":false},{"name":"José A. López-Martín","is_ca":false},{"name":"Wilson H. Miller","is_ca":true},{"name":"Antoîne Italiano","is_ca":false},{"name":"Steven Kao","is_ca":false},{"name":"Sarina A. Piha‐Paul","is_ca":false},{"name":"Jean‐Pierre Delord","is_ca":false},{"name":"Robert R. McWilliams","is_ca":false},{"name":"David Fabrizio","is_ca":false},{"name":"Deepti Aurora-Garg","is_ca":false},{"name":"Lei Xu","is_ca":false},{"name":"Fan Jin","is_ca":false},{"name":"Kevin Norwood","is_ca":false},{"name":"Yung‐Jue Bang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03122114611269687,"gpt":0.3549706413578277,"spread":0.3237494952451308,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002044662,0.0005779573,0.0008804951,0.0002999585,0.0002637473,0.0009462599,0.0004744206,0.0007805817,0.001038533],"category_scores_gemma":[0.002396993,0.0003890384,0.001208496,0.0005414016,0.00032742,0.0009004441,0.000548395,0.001114607,0.0002096881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003302834,"about_ca_system_score_gemma":0.0002602457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004088657,"about_ca_topic_score_gemma":0.0006477624,"domain_scores_codex":[0.9992494,0.0003395058,0.00004875937,0.0002002903,0.0000804466,0.00008168501],"domain_scores_gemma":[0.9979256,0.0005268918,0.000928387,0.0002651329,0.0001197622,0.0002341068],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1576905,0.001284371,0.7985094,0.0003973178,0.008238673,0.0001557756,0.0001610856,0.001227037,0.008561851,0.0001818771,0.001443428,0.02214871],"study_design_scores_gemma":[0.007741352,0.01045787,0.9749591,0.00004000811,0.003151659,0.0002958422,0.00009875603,0.001207453,0.0007344431,0.0003059846,0.0009699062,0.00003763095],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980667,0.0008749082,0.0001060147,0.00006018845,0.00001311712,0.00002589774,0.0006366805,0.000005697666,0.0002108506],"genre_scores_gemma":[0.9983196,0.0002194005,0.0001402587,0.00007901016,0.00003278097,0.00003825469,0.0009819688,0.000004325914,0.000184426],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002044662,"threshold_uncertainty_score":0.01081336,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2592144107","doi":"10.1016/s1470-2045(17)30074-8","title":"iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics","year":2017,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2408,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Guideline; Clinical trial; Medicine; Medical physics; Response Evaluation Criteria in Solid Tumors; Immunotherapy; Cancer; Intensive care medicine; Oncology; Internal medicine; Pathology","authors":[{"name":"Lesley Seymour","is_ca":true},{"name":"Jan Bogaerts","is_ca":false},{"name":"Andrea Perrone","is_ca":false},{"name":"Robert Ford","is_ca":false},{"name":"Lawrence H. Schwartz","is_ca":false},{"name":"Sumithra J. Mandrekar","is_ca":false},{"name":"Nancy U. Lin","is_ca":false},{"name":"Saskia Litière","is_ca":false},{"name":"Janet Dancey","is_ca":true},{"name":"Alice Chen","is_ca":false},{"name":"F. Stephen Hodi","is_ca":false},{"name":"Patrick Therasse","is_ca":false},{"name":"Otto S. Hoekstra","is_ca":false},{"name":"Lalitha Shankar","is_ca":false},{"name":"Jedd D. Wolchok","is_ca":false},{"name":"Marcus Ballinger","is_ca":false},{"name":"Caroline Caramella","is_ca":false},{"name":"Elisabeth G.E. de Vries","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.8623875272759276,"gpt":0.6325735133841923,"spread":0.2298140138917353,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1349909,0.003440459,0.01252942,0.009299776,0.002077428,0.009136073,0.008366374,0.009820137,0.02228388],"category_scores_gemma":[0.22507,0.002080813,0.01696014,0.007763213,0.003562039,0.004254583,0.008199942,0.01316734,0.01493832],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006520491,"about_ca_system_score_gemma":0.01940069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004107356,"about_ca_topic_score_gemma":0.008364408,"domain_scores_codex":[0.8593028,0.07368834,0.04572547,0.002145861,0.0168187,0.002318891],"domain_scores_gemma":[0.7733223,0.1577296,0.02770566,0.006530099,0.03186608,0.002846226],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002605387,0.0001503663,0.001336166,0.1290278,0.003058723,0.0001754469,0.0006869669,0.0009350352,0.000937429,0.01450458,0.3442957,0.5022865],"study_design_scores_gemma":[0.002830973,0.0004273887,0.003979693,0.1518821,0.00449629,0.0004792835,0.0002905843,0.0006331754,0.00107662,0.0261819,0.8075159,0.0002061102],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"methods","genre_scores_codex":[0.001252779,0.7475554,0.05752648,0.07057121,0.01607583,0.03137224,0.02504126,0.003536735,0.04706803],"genre_scores_gemma":[0.02066108,0.2780234,0.3852513,0.1268914,0.008644222,0.1216651,0.03247377,0.002347013,0.02404267],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.8650091,"threshold_uncertainty_score":0.7139089,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2123591186","doi":"10.1016/s1470-2045(11)70336-9","title":"Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2358,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Pertuzumab; Trastuzumab; Docetaxel; Medicine; Internal medicine; Clinical endpoint; Breast cancer; Oncology; Population; Chemotherapy; Clinical trial; Cancer","authors":[{"name":"Luca Gianni","is_ca":false},{"name":"Tadeusz Pieńkowski","is_ca":false},{"name":"Young‐Hyuck Im","is_ca":false},{"name":"Laslo Roman","is_ca":false},{"name":"Ling‐Ming Tseng","is_ca":false},{"name":"Mei-Ching Liu","is_ca":false},{"name":"Aňa Lluch","is_ca":false},{"name":"Elżbieta Starosławska","is_ca":false},{"name":"Juan de la Haba-Rodríguez","is_ca":false},{"name":"Seock‐Ah Im","is_ca":false},{"name":"José Luiz Pedrini","is_ca":false},{"name":"Brigitte Poirier","is_ca":true},{"name":"Paolo Morandi","is_ca":false},{"name":"Semiglazov Vf","is_ca":false},{"name":"Vichien Srimuninnimit","is_ca":false},{"name":"Giulia Bianchi","is_ca":false},{"name":"Tania Szado","is_ca":false},{"name":"Jayantha Ratnayake","is_ca":false},{"name":"Graham Ross","is_ca":false},{"name":"Pinuccia Valagussa","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06039123479763487,"gpt":0.3881995916148677,"spread":0.3278083568172329,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001753153,0.00178147,0.00227994,0.0003637272,0.0003305751,0.0009581393,0.00083788,0.002071146,0.005738767],"category_scores_gemma":[0.002160263,0.0008675606,0.001584232,0.0003744978,0.001581891,0.001523786,0.0005098716,0.003133686,0.00101437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001071718,"about_ca_system_score_gemma":0.0009633532,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007091829,"about_ca_topic_score_gemma":0.001611583,"domain_scores_codex":[0.9993394,0.0003898284,0.00002745304,0.0001043741,0.00004291056,0.00009605695],"domain_scores_gemma":[0.9989781,0.0003371625,0.0001951616,0.00008698743,0.00003981611,0.0003627707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9806631,0.003770045,0.0006735985,0.0001791036,0.0003697191,0.00002758768,0.00005538426,0.0003106173,0.00253304,0.00006034163,0.0003911775,0.0109662],"study_design_scores_gemma":[0.875684,0.1199451,0.002348685,0.0000184444,0.0003468345,0.00005716455,0.00003092004,0.0003720478,0.0004540383,0.0001864646,0.0005392975,0.000017003],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950448,0.001832439,0.0002065504,0.000617025,0.000204571,0.000618451,0.0004117519,0.00004004815,0.001024329],"genre_scores_gemma":[0.9911761,0.001587286,0.0006657872,0.0008947636,0.0003255791,0.001336625,0.001083626,0.00002379462,0.002906492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005738767,"threshold_uncertainty_score":0.01919806,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2160305510","doi":"10.1016/s1470-2045(06)70664-7","title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group","year":2006,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2085,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; CHOP; Internal medicine; Vincristine; International Prognostic Index; Chemotherapy; Clinical endpoint; Diffuse large B-cell lymphoma; Lymphoma; Oncology; Prednisone; Surgery; Cyclophosphamide; Gastroenterology; Randomized controlled trial","authors":[{"name":"Michael Pfreundschuh","is_ca":false},{"name":"Lorenz Trümper","is_ca":false},{"name":"Anders Österborg","is_ca":false},{"name":"Ruth Pettengell","is_ca":false},{"name":"Marek Trněný","is_ca":false},{"name":"Kevin Imrie","is_ca":true},{"name":"Dávid Ma","is_ca":false},{"name":"Devinder Gill","is_ca":false},{"name":"Jan Walewski","is_ca":false},{"name":"Pier Luigi Zinzani","is_ca":false},{"name":"Rolf A. Stahel","is_ca":false},{"name":"Stein Kvaløy","is_ca":false},{"name":"Ofer Shpilberg","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Mads Hansen","is_ca":false},{"name":"Tuula Lehtinen","is_ca":false},{"name":"Armando López‐Guillermo","is_ca":false},{"name":"Claudia Corrado","is_ca":false},{"name":"Adriana Scheliga","is_ca":false},{"name":"Nöel Milpied","is_ca":false},{"name":"Myriam Mendila","is_ca":false},{"name":"Michelle Rashford","is_ca":false},{"name":"Evelyn Kuhnt","is_ca":false},{"name":"Markus Loeffler","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01156893336735901,"gpt":0.2673967495049783,"spread":0.2558278161376193,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001956614,0.002048878,0.005767155,0.0005161345,0.0005202626,0.001339511,0.001094562,0.002777662,0.005985349],"category_scores_gemma":[0.002800178,0.0009257178,0.003344809,0.0006558938,0.001491311,0.001941447,0.0007132071,0.004460687,0.001043128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001027621,"about_ca_system_score_gemma":0.000977688,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001480267,"about_ca_topic_score_gemma":0.002120411,"domain_scores_codex":[0.9990419,0.0005227689,0.00007230869,0.0001794035,0.00004727643,0.0001363624],"domain_scores_gemma":[0.9987376,0.0004555987,0.0002716207,0.00009902925,0.00005832054,0.0003778993],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9932991,0.0008971936,0.0002109587,0.0004119562,0.0007702112,0.0000180658,0.00002474755,0.00009774666,0.0004376878,0.00005639039,0.0002399582,0.003535962],"study_design_scores_gemma":[0.9759012,0.02206898,0.0007324062,0.00004157587,0.0006505417,0.00001866996,0.00001865295,0.000129165,0.00008238579,0.0001207822,0.0002261576,0.000009492495],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9734899,0.01630506,0.0009057404,0.001623888,0.002241536,0.002537628,0.0009747397,0.0001320138,0.001789549],"genre_scores_gemma":[0.9828671,0.005885602,0.001544894,0.001689177,0.00103533,0.003615452,0.0007649083,0.00003066957,0.00256685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005985349,"threshold_uncertainty_score":0.02002299,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1968899146","doi":"10.1016/s1470-2045(14)71207-0","title":"Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2007,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Carboplatin; Medicine; Cetuximab; Paclitaxel; Oncology; Radiation therapy; Stage (stratigraphy); Internal medicine; Lung cancer; Chemotherapy; Nuclear medicine; Cancer; Cisplatin; Colorectal cancer","authors":[{"name":"Jeffrey D. Bradley","is_ca":false},{"name":"Rebecca Paulus","is_ca":false},{"name":"Ritsuko Komaki","is_ca":false},{"name":"Gregory A. Masters","is_ca":false},{"name":"George Blumenschein","is_ca":false},{"name":"Steven E. Schild","is_ca":false},{"name":"Jeffrey A. Bogart","is_ca":false},{"name":"Chen Hu","is_ca":false},{"name":"Kenneth Forster","is_ca":false},{"name":"Anthony M. Magliocco","is_ca":false},{"name":"Vivek S. Kavadi","is_ca":false},{"name":"Yolanda I. Garces","is_ca":false},{"name":"Samir Narayan","is_ca":false},{"name":"Puneeth Iyengar","is_ca":false},{"name":"Clifford G. Robinson","is_ca":false},{"name":"Raymond B. Wynn","is_ca":false},{"name":"Christopher D. Koprowski","is_ca":false},{"name":"Joanne Meng","is_ca":true},{"name":"Jonathan J. Beitler","is_ca":false},{"name":"Rakesh Gaur","is_ca":false},{"name":"Walter J. Curran","is_ca":false},{"name":"Hak Choy","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04436868744910295,"gpt":0.3865590085254279,"spread":0.342190321076325,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002420452,0.002377745,0.004434626,0.0008018501,0.0004495181,0.001362469,0.001951736,0.002121725,0.00782836],"category_scores_gemma":[0.001956238,0.001295199,0.003991658,0.0008980073,0.002358561,0.001478203,0.000722323,0.004676122,0.001286695],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001685327,"about_ca_system_score_gemma":0.001944657,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002749619,"about_ca_topic_score_gemma":0.004438695,"domain_scores_codex":[0.9988537,0.0006356026,0.00005774694,0.0001884598,0.00007167093,0.0001928216],"domain_scores_gemma":[0.9986145,0.000425065,0.0003106182,0.0001522663,0.00005131766,0.0004462044],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9835292,0.005657401,0.0002783931,0.0002470906,0.0005630598,0.00001352381,0.0000456622,0.0005549426,0.00114079,0.00005828778,0.0002876708,0.007624083],"study_design_scores_gemma":[0.9130501,0.08463964,0.00100664,0.00001592329,0.0003484672,0.0000176666,0.00002226936,0.000320162,0.0002395023,0.0001078295,0.0002189604,0.00001273827],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934607,0.001831272,0.0004754139,0.0003916859,0.0004865153,0.001696595,0.0004967764,0.00007939267,0.001081756],"genre_scores_gemma":[0.9901779,0.001901594,0.001452247,0.0006916277,0.0004651872,0.001952641,0.0006459535,0.0000518519,0.002660971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00782836,"threshold_uncertainty_score":0.02618843,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2151730005","doi":"10.1016/s1470-2045(09)70311-0","title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","year":2009,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1974,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Cetuximab; Head and neck cancer; Clinical endpoint; Radiation therapy; Rash; Internal medicine; Oncology; Head and neck squamous-cell carcinoma; Randomized controlled trial; Surgery; Cancer; Colorectal cancer","authors":[{"name":"James A. Bonner","is_ca":false},{"name":"Paul M. Harari","is_ca":false},{"name":"J. Giralt","is_ca":false},{"name":"Roger B. Cohen","is_ca":false},{"name":"Christopher U. Jones","is_ca":false},{"name":"Ranjan Sur","is_ca":true},{"name":"David Raben","is_ca":false},{"name":"José Baselga","is_ca":false},{"name":"Sharon A. Spencer","is_ca":false},{"name":"Junming Zhu","is_ca":false},{"name":"Hagop Youssoufian","is_ca":false},{"name":"Eric K. Rowinsky","is_ca":false},{"name":"K. Kian Ang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.154146220113929,"gpt":0.4342346987075292,"spread":0.2800884785936002,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006451491,0.001415377,0.003009416,0.0005018892,0.0005995316,0.001255368,0.00124353,0.002032906,0.004501455],"category_scores_gemma":[0.005237443,0.0007539579,0.005175913,0.0009016186,0.001388576,0.001375457,0.0007166547,0.003562228,0.0005476194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001548452,"about_ca_system_score_gemma":0.001380599,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004067952,"about_ca_topic_score_gemma":0.00948139,"domain_scores_codex":[0.997216,0.001826426,0.0002111424,0.0003049633,0.0001950163,0.0002465538],"domain_scores_gemma":[0.9962902,0.001696449,0.0009820875,0.0003867312,0.0001573618,0.0004871279],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9767371,0.001640705,0.003604219,0.0008217728,0.005856882,0.00003002129,0.00006291617,0.0006629151,0.001263109,0.0000621075,0.0004899695,0.008768307],"study_design_scores_gemma":[0.8330896,0.1128537,0.0380418,0.0001831875,0.01240484,0.0001523104,0.0001074415,0.0005914138,0.0008497033,0.000345172,0.001318702,0.00006207904],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9829423,0.01306615,0.0003064738,0.0005603518,0.0002764815,0.0005708669,0.001223447,0.00002877864,0.0010249],"genre_scores_gemma":[0.9908726,0.004407254,0.0003798693,0.0006202167,0.0002163344,0.0004555088,0.001606145,0.00002004661,0.001422154],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006451491,"threshold_uncertainty_score":0.03411913,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131719808","doi":"10.1016/s1470-2045(10)70207-2","title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","year":2010,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1919,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Saint John Regional Hospital; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Axillary Lymph Node Dissection; Sentinel lymph node; Breast cancer; Lumpectomy; Mastectomy; Surgery; Axilla; Sentinel node; Lymph node; Clinical endpoint; Randomized controlled trial; Cancer; Internal medicine","authors":[{"name":"David N. Krag","is_ca":false},{"name":"Stewart Anderson","is_ca":false},{"name":"Thomas B. Julian","is_ca":false},{"name":"Ann Brown","is_ca":false},{"name":"Seth P. Harlow","is_ca":false},{"name":"Joseph P. Costantino","is_ca":false},{"name":"Takamaru Ashikaga","is_ca":false},{"name":"Donald L. Weaver","is_ca":false},{"name":"Eleftherios P. Mamounas","is_ca":false},{"name":"Lynne M Jalovec","is_ca":false},{"name":"Thomas G. Frazier","is_ca":false},{"name":"R. Dirk Noyes","is_ca":false},{"name":"André Robidoux","is_ca":true},{"name":"Hugh MC Scarth","is_ca":true},{"name":"Norman Wolmark","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02129551545244373,"gpt":0.3209903072835433,"spread":0.2996947918310996,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00219265,0.001884886,0.002069503,0.0002630978,0.0002160485,0.0008429307,0.0007569106,0.001234099,0.004579943],"category_scores_gemma":[0.002263119,0.000447553,0.002547815,0.000369845,0.001229752,0.001138136,0.0004893037,0.002830077,0.0006756822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008482582,"about_ca_system_score_gemma":0.0008959835,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001724691,"about_ca_topic_score_gemma":0.003992388,"domain_scores_codex":[0.9992173,0.0005317351,0.00003491289,0.0000981151,0.00004387175,0.00007407586],"domain_scores_gemma":[0.9987561,0.0005536634,0.0002585225,0.0001013076,0.00004230337,0.0002882146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9831961,0.0009414871,0.001125562,0.0004269965,0.001105612,0.00002215885,0.00004226145,0.0004456927,0.001183641,0.00006236927,0.0006035135,0.01084449],"study_design_scores_gemma":[0.9129974,0.06693444,0.01445041,0.0001093639,0.00249199,0.00008164519,0.0001064736,0.0007057821,0.0005693958,0.0006749534,0.0008473817,0.00003078814],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888309,0.006781208,0.0002591014,0.001275243,0.0003986368,0.0002406662,0.0007607854,0.00004699963,0.001406511],"genre_scores_gemma":[0.993024,0.002863829,0.0003736963,0.0007634052,0.0002326046,0.0002509397,0.0006010775,0.00001710053,0.001873414],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004579943,"threshold_uncertainty_score":0.01532137,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2737389832","doi":"10.1016/s1470-2045(17)30469-2","title":"Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1863,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"European Society for Medical Oncology","keywords":"Olaparib; Medicine; BRCA mutation; Ovarian cancer; Internal medicine; Oncology; Placebo; PARP inhibitor; Clinical endpoint; Population; Randomized controlled trial; Cancer; Pathology","authors":[{"name":"Éric Pujade-Lauraine","is_ca":false},{"name":"Jonathan A. Ledermann","is_ca":false},{"name":"Frédèric Selle","is_ca":false},{"name":"Val Gebski","is_ca":false},{"name":"Richard T. Penson","is_ca":false},{"name":"Amit M. Oza","is_ca":true},{"name":"Jacob Korach","is_ca":false},{"name":"Tomasz Huzarski","is_ca":false},{"name":"Andrés Poveda","is_ca":false},{"name":"Sandro Pignata","is_ca":false},{"name":"Michael Friedländer","is_ca":false},{"name":"Nicoletta Colombo","is_ca":false},{"name":"Philipp Harter","is_ca":false},{"name":"Keiichi Fujiwara","is_ca":false},{"name":"Isabelle Ray‐Coquard","is_ca":false},{"name":"Susana Banerjee","is_ca":false},{"name":"Joyce F. Liu","is_ca":false},{"name":"Elizabeth Lowe","is_ca":false},{"name":"Ralph Bloomfield","is_ca":false},{"name":"Patricia Pautier","is_ca":false},{"name":"Tomasz Byrski","is_ca":false},{"name":"Giovanni Scambia","is_ca":false},{"name":"Maria Ornella Nicoletto","is_ca":false},{"name":"Fiona Nussey","is_ca":false},{"name":"Andrew R. Clamp","is_ca":false},{"name":"A. Poveda Velasco","is_ca":false},{"name":"Manuel Rodrigues","is_ca":false},{"name":"Jean‐Pierre Lotz","is_ca":false},{"name":"Diane Provencher","is_ca":false},{"name":"Aleix Prat Aparicio","is_ca":false},{"name":"Laura Vidal Boixader","is_ca":false},{"name":"Clare L. Scott","is_ca":false},{"name":"Kenji Tamura","is_ca":false},{"name":"Mayu Yunokawa","is_ca":false},{"name":"Alla Lisyanskaya","is_ca":false},{"name":"Jacques Médioni","is_ca":false},{"name":"Nicolas Pécuchet","is_ca":false},{"name":"Coraline Dubot","is_ca":false},{"name":"Thibault De La Motte Rouge","is_ca":false},{"name":"Marie‐Christine Kaminsky","is_ca":false},{"name":"B. Weber","is_ca":false},{"name":"Alain Lortholary","is_ca":false},{"name":"Christine Parkinson","is_ca":false},{"name":"Sarah Williams","is_ca":false},{"name":"Jonathan A. Cosin","is_ca":false},{"name":"James Hoffman","is_ca":false},{"name":"Marie Plante","is_ca":false},{"name":"Allan Covens","is_ca":false},{"name":"Gabe S. Sonke","is_ca":false},{"name":"Florence Joly","is_ca":false},{"name":"Anne Floquet","is_ca":false},{"name":"Holger W. Hirte","is_ca":false},{"name":"Amnon Amit","is_ca":true},{"name":"Tjoung-Won Park-Simon","is_ca":false},{"name":"Koji Matsumoto","is_ca":false},{"name":"Sergei Tjulandin","is_ca":false},{"name":"Jae‐Hoon Kim","is_ca":false},{"name":"Laurence Gladieff","is_ca":false},{"name":"Roberto Sabbatini","is_ca":false},{"name":"David M. O’Malley","is_ca":false},{"name":"Patrick Timmins","is_ca":false},{"name":"Daniel Kredentser","is_ca":false},{"name":"Nuria Laínez Milagro","is_ca":false},{"name":"M.P. Barretina Ginesta","is_ca":false},{"name":"Ariadna Tibau Martorell","is_ca":false},{"name":"Alfonso Gómez de Liaño","is_ca":false},{"name":"Belén Ojeda González","is_ca":false},{"name":"Linda Mileshkin","is_ca":false},{"name":"Masaki Mandai","is_ca":false},{"name":"Ingrid Boere","is_ca":false},{"name":"Petronella B. Ottevanger","is_ca":false},{"name":"Joo‐Hyun Nam","is_ca":false},{"name":"Elias Abdo Filho","is_ca":false},{"name":"Salima Hamizi","is_ca":false},{"name":"Francesco Cognetti","is_ca":false},{"name":"David Warshal","is_ca":false},{"name":"Elizabeth Dickson-Michelson","is_ca":false},{"name":"Scott Kamelle","is_ca":false},{"name":"Nathalie D. McKenzie","is_ca":false},{"name":"Gustavo C. Rodriguez","is_ca":false},{"name":"Deborah K. Armstrong","is_ca":false},{"name":"Eva Chalas","is_ca":false},{"name":"Paul Celano","is_ca":false},{"name":"Kian Behbakht","is_ca":false},{"name":"Susan A. Davidson","is_ca":false},{"name":"Stephen Welch","is_ca":false},{"name":"Limor Helpman","is_ca":false},{"name":"Ami Fishman","is_ca":true},{"name":"Ilan Bruchim","is_ca":false},{"name":"Magdalena Sikorska","is_ca":false},{"name":"Anna Słowińska","is_ca":false},{"name":"Wojciech Rogowski","is_ca":false},{"name":"Mariusz Bidziński","is_ca":false},{"name":"Beata Śpiewankiewicz","is_ca":false},{"name":"César Mendiola Fernández","is_ca":false},{"name":"Martina Gropp‐Meier","is_ca":false},{"name":"Toshiaki Saito","is_ca":false},{"name":"Kazuhiro Takehara","is_ca":false},{"name":"Takayuki Enomoto","is_ca":false},{"name":"Hidemichi Watari","is_ca":false},{"name":"Chel Hun Choi","is_ca":false},{"name":"Byoung‐Gie Kim","is_ca":false},{"name":"Jae‐Weon Kim","is_ca":false},{"name":"Roberto Hegg","is_ca":false},{"name":"Ignace Vergote","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05211112076256093,"gpt":0.3733703096465478,"spread":0.3212591888839869,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001239456,0.001576358,0.003857015,0.0004692595,0.0004052796,0.001203483,0.001050745,0.002072104,0.005457962],"category_scores_gemma":[0.001461497,0.0007361307,0.001620888,0.0005165866,0.001183337,0.001447535,0.0003967291,0.003305672,0.001127722],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004913835,"about_ca_system_score_gemma":0.0006703214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006364763,"about_ca_topic_score_gemma":0.001300518,"domain_scores_codex":[0.9995677,0.000210682,0.00003058339,0.00009420187,0.00003203859,0.0000647472],"domain_scores_gemma":[0.9992898,0.000233242,0.0001350925,0.00005843966,0.00003503199,0.0002484407],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9766582,0.002404445,0.0003454743,0.0007508692,0.0006095035,0.00004274384,0.00004469023,0.0002192743,0.002060042,0.00007428463,0.0007083566,0.01608212],"study_design_scores_gemma":[0.9659812,0.0317253,0.0009189216,0.00003299423,0.0002171959,0.00003794597,0.00001675386,0.0002665651,0.0002026142,0.0001147373,0.0004722469,0.00001345903],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9747771,0.01521659,0.0009407399,0.001065148,0.0008130848,0.002624808,0.001505517,0.000298187,0.002758751],"genre_scores_gemma":[0.9829664,0.006303541,0.00143255,0.00148421,0.0005121696,0.002032467,0.001457764,0.00004359632,0.003767189],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005457962,"threshold_uncertainty_score":0.01825869,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2290950904","doi":"10.1016/s1470-2045(15)00613-0","title":"Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1822,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; University of Calgary","funders":"University of California, Los Angeles; Novartis; Daiichi-Sankyo; Pfizer; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline; U.S. Department of Defense","keywords":"Fulvestrant; Palbociclib; Metastatic breast cancer; Medicine; Placebo; Internal medicine; Oncology; Gynecology; Cancer; Breast cancer; Estrogen receptor","authors":[{"name":"Massimo Cristofanilli","is_ca":false},{"name":"Nicholas C. Turner","is_ca":false},{"name":"Igor Bondarenko","is_ca":false},{"name":"Jungsil Ro","is_ca":false},{"name":"Seock‐Ah Im","is_ca":false},{"name":"Norikazu Masuda","is_ca":false},{"name":"Marco Colleoni","is_ca":false},{"name":"Angela DeMichele","is_ca":false},{"name":"Sherene Loi","is_ca":false},{"name":"Sunil Verma","is_ca":true},{"name":"Hiroji Iwata","is_ca":false},{"name":"Nadia Harbeck","is_ca":false},{"name":"Ke Zhang","is_ca":false},{"name":"Kathy Puyana Theall","is_ca":false},{"name":"Yuqiu Jiang","is_ca":false},{"name":"Cynthia Huang Bartlett","is_ca":false},{"name":"María Koehler","is_ca":false},{"name":"Dennis J. Slamon","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1235990477317247,"gpt":0.4149209742192354,"spread":0.2913219264875107,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002516419,0.002579488,0.003969922,0.0005987741,0.0004052526,0.001291883,0.001357067,0.001918248,0.008257579],"category_scores_gemma":[0.002715634,0.0007694033,0.003839853,0.0005486463,0.001387201,0.001594343,0.0005516667,0.00348331,0.00120975],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001071077,"about_ca_system_score_gemma":0.001029497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00165235,"about_ca_topic_score_gemma":0.003537167,"domain_scores_codex":[0.9990838,0.0005325862,0.00005834198,0.0001425142,0.00005108925,0.0001316262],"domain_scores_gemma":[0.9990283,0.0003794587,0.0002279654,0.00009109511,0.00005873504,0.0002144248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9918806,0.0006768257,0.00008925319,0.0005579384,0.0008320248,0.00001315231,0.00002136042,0.0001700934,0.0007900264,0.00005625146,0.0002629912,0.004649439],"study_design_scores_gemma":[0.9849277,0.01371717,0.0003925062,0.00002493217,0.0003705115,0.00001063229,0.00001045584,0.0001669237,0.00009949099,0.00009213231,0.0001793921,0.000008164335],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9691883,0.01538618,0.001928907,0.001315055,0.00176379,0.005205363,0.002014484,0.0003884335,0.002809467],"genre_scores_gemma":[0.9828025,0.00474521,0.001950554,0.001082356,0.0005702908,0.003742935,0.001040534,0.00005032662,0.004015274],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008257579,"threshold_uncertainty_score":0.02762431,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2946386783","doi":"10.1016/s1470-2045(19)30167-6","title":"Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1681,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"William Osler Health System","funders":"F. Hoffmann-La Roche","keywords":"Carboplatin; Medicine; Paclitaxel; Atezolizumab; Chemotherapy; Oncology; Nab-paclitaxel; Open label; Internal medicine; Lung cancer; Cisplatin; Cancer; Randomized controlled trial; Nivolumab; Immunotherapy","authors":[{"name":"Howard West","is_ca":false},{"name":"Michael McCleod","is_ca":false},{"name":"Maen Hussein","is_ca":false},{"name":"Alessandro Morabito","is_ca":false},{"name":"Achim Rittmeyer","is_ca":false},{"name":"Henry Jacob Conter","is_ca":true},{"name":"Hans‐Georg Kopp","is_ca":false},{"name":"Davey B. Daniel","is_ca":false},{"name":"Steven McCune","is_ca":false},{"name":"Tarek Mekhail","is_ca":false},{"name":"Alona Zer","is_ca":false},{"name":"Niels Reinmuth","is_ca":false},{"name":"Ahad A. Sadiq","is_ca":false},{"name":"Alan Sandler","is_ca":false},{"name":"Wei Lin","is_ca":false},{"name":"Tania Ochi Lohmann","is_ca":false},{"name":"Venice Archer","is_ca":false},{"name":"Lijia Wang","is_ca":false},{"name":"Marcin Kowanetz","is_ca":false},{"name":"Federico Cappuzzo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04848363890646765,"gpt":0.3745263839184664,"spread":0.3260427450119987,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001436069,0.001654114,0.003255459,0.0004323825,0.0002972732,0.001330272,0.001050701,0.001718516,0.005388233],"category_scores_gemma":[0.001600775,0.0006528576,0.002665903,0.0004110274,0.001095064,0.001309871,0.0005818301,0.004262108,0.001004379],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008365454,"about_ca_system_score_gemma":0.0008349705,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001128154,"about_ca_topic_score_gemma":0.002456475,"domain_scores_codex":[0.999467,0.0002713145,0.00002721836,0.0001078579,0.00004012597,0.00008655836],"domain_scores_gemma":[0.9993384,0.0002209096,0.0001440123,0.00004824136,0.00003468196,0.0002136695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9768663,0.003732312,0.0004754365,0.0005931242,0.001077492,0.0000234917,0.00005103008,0.0003888814,0.001942782,0.0001040249,0.0008094474,0.01393559],"study_design_scores_gemma":[0.9091512,0.0872168,0.001623417,0.00003647053,0.0005854188,0.00003762478,0.00002580048,0.0004491236,0.000259013,0.0001356174,0.0004628479,0.00001657619],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893066,0.004456061,0.0004360082,0.0007439046,0.000680422,0.00139186,0.0009042886,0.0001335074,0.001947351],"genre_scores_gemma":[0.989004,0.002355227,0.001054181,0.0009492929,0.0004053717,0.001457063,0.001224642,0.00003598972,0.003514351],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005388233,"threshold_uncertainty_score":0.0180254,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2132870547","doi":"10.1016/s1470-2045(14)71173-8","title":"Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1580,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Boehringer Ingelheim","keywords":"Medicine; Afatinib; Pemetrexed; Lung cancer; Internal medicine; Adenocarcinoma; Lung; Gemcitabine; Chemotherapy; Population; Gastroenterology; Oncology; Cisplatin; Surgery; Gefitinib; Epidermal growth factor receptor; Cancer","authors":[{"name":"James Chih‐Hsin Yang","is_ca":false},{"name":"Yi‐Long Wu","is_ca":false},{"name":"Martin Schüler","is_ca":false},{"name":"Martin Sebastian","is_ca":false},{"name":"Sanjay Popat","is_ca":false},{"name":"Nobuyuki Yamamoto","is_ca":false},{"name":"Caicun Zhou","is_ca":false},{"name":"Cheng-Ping Hu","is_ca":false},{"name":"Kenneth J. O’Byrne","is_ca":false},{"name":"Jifeng Feng","is_ca":false},{"name":"Shun Lü","is_ca":false},{"name":"Yunchao Huang","is_ca":false},{"name":"Sarayut Lucien Geater","is_ca":false},{"name":"Kye Young Lee","is_ca":false},{"name":"Chun-Ming Tsai","is_ca":false},{"name":"В. А. Горбунова","is_ca":false},{"name":"Vera Hirsh","is_ca":true},{"name":"Jaafar Bennouna","is_ca":false},{"name":"С. В. Орлов","is_ca":false},{"name":"Tony Mok","is_ca":false},{"name":"Michael Boyer","is_ca":false},{"name":"Wu‐Chou Su","is_ca":false},{"name":"Ki Hyeong Lee","is_ca":false},{"name":"Terufumi Kato","is_ca":false},{"name":"Dan Massey","is_ca":false},{"name":"Mehdi Shahidi","is_ca":false},{"name":"Victoria Zazulina","is_ca":false},{"name":"Lecia V. Sequist","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1710050663165039,"gpt":0.4951860196022361,"spread":0.3241809532857323,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005279308,0.001518481,0.003908913,0.000515877,0.0003292905,0.001347054,0.001205662,0.001826663,0.003662114],"category_scores_gemma":[0.005747153,0.0005550613,0.006175588,0.0007252072,0.001506886,0.002081972,0.0006306953,0.004067939,0.0005296491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001336337,"about_ca_system_score_gemma":0.0008760226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001016939,"about_ca_topic_score_gemma":0.002956656,"domain_scores_codex":[0.9974962,0.001733726,0.000168221,0.0002662136,0.0001378231,0.000197769],"domain_scores_gemma":[0.9969276,0.001467396,0.0007643172,0.0002675264,0.0001156234,0.0004575949],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9632995,0.001149808,0.001006601,0.00145248,0.004647218,0.0000335134,0.00007780366,0.001240766,0.001405236,0.0001521305,0.0007252824,0.02480973],"study_design_scores_gemma":[0.9340686,0.05596494,0.003807032,0.0001143321,0.003269413,0.0001108563,0.0000555375,0.0006776191,0.0003682862,0.0005980806,0.0009255196,0.00003991018],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9690295,0.02401806,0.00103135,0.00112723,0.0004751954,0.001236202,0.001280729,0.00009717297,0.001704579],"genre_scores_gemma":[0.9885609,0.005931124,0.001204971,0.0007764235,0.0001888277,0.0008931204,0.001192931,0.00003383774,0.00121789],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005279308,"threshold_uncertainty_score":0.02791995,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2145426305","doi":"10.1016/s1470-2045(05)70101-7","title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","year":2005,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1580,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Placebo; Medicine; Double blind; Virus-like particle; Human papillomavirus; Internal medicine; Virology; Recombinant DNA; Alternative medicine; Pathology; Biology","authors":[{"name":"Luisa L. Villa","is_ca":false},{"name":"Ronaldo Lúcio Rangel Costa","is_ca":false},{"name":"Carlos Alberto Petta","is_ca":false},{"name":"Rosíres Pereira de Andrade","is_ca":false},{"name":"Kevin A. Ault","is_ca":false},{"name":"Anna R. Giuliano","is_ca":false},{"name":"Cosette M. Wheeler","is_ca":false},{"name":"Laura A. Koutsky","is_ca":false},{"name":"Christian Malm","is_ca":false},{"name":"Matti Lehtinen","is_ca":false},{"name":"Finn Egil Skjeldestad","is_ca":false},{"name":"Sven-Eric Olsson","is_ca":false},{"name":"Margareta Steinwall","is_ca":false},{"name":"Darron R. Brown","is_ca":false},{"name":"Robert J. Kurman","is_ca":false},{"name":"Brigitte M. Ronnett","is_ca":false},{"name":"Mark H. Stoler","is_ca":false},{"name":"Alex Ferenczy","is_ca":true},{"name":"Diane M. Harper","is_ca":false},{"name":"Gretchen Tamms","is_ca":false},{"name":"Jimmy Yu","is_ca":false},{"name":"Lisa Lupinacci","is_ca":false},{"name":"Radha Railkar","is_ca":false},{"name":"Frank J. Taddeo","is_ca":false},{"name":"Kathrin U. Jansen","is_ca":false},{"name":"Mark T. Esser","is_ca":false},{"name":"Heather L. Sings","is_ca":false},{"name":"Alfred J. Saah","is_ca":false},{"name":"Eliav Barr","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08610090242738114,"gpt":0.4192445002258663,"spread":0.3331435977984851,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001990662,0.002064291,0.004730578,0.0006136573,0.0006151417,0.001020476,0.001117744,0.002971969,0.006895732],"category_scores_gemma":[0.002111407,0.001169866,0.001743772,0.0005469611,0.001652447,0.001134853,0.0005045129,0.002901894,0.001261724],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008741328,"about_ca_system_score_gemma":0.001393702,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001823968,"about_ca_topic_score_gemma":0.00254031,"domain_scores_codex":[0.9993308,0.0003137109,0.00003923,0.0001318604,0.00005635706,0.0001281718],"domain_scores_gemma":[0.9989561,0.0003170313,0.0001870852,0.00008719457,0.00005765699,0.0003949361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9855924,0.003977913,0.0002875288,0.000385352,0.0003830178,0.00002724765,0.00006317265,0.0001067498,0.001815409,0.00005593873,0.0004139419,0.006891286],"study_design_scores_gemma":[0.9637238,0.03493818,0.0006946464,0.00001506475,0.0001609227,0.00001253278,0.00001278154,0.00006361974,0.0001289933,0.00005266099,0.0001900599,0.000006591152],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848704,0.005328064,0.0009079545,0.0008576173,0.0008837725,0.004149185,0.001383314,0.0001638805,0.001455737],"genre_scores_gemma":[0.9806105,0.004229221,0.001647857,0.001597405,0.000608083,0.005523039,0.001114789,0.00003946374,0.004629569],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006895732,"threshold_uncertainty_score":0.02306849,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2165693726","doi":"10.1016/s1470-2045(08)70179-7","title":"Cancer survival in five continents: a worldwide population-based study (CONCORD)","year":2008,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1469,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Relative survival; Medicine; Demography; Cancer; Population; Cancer registry; Breast cancer; Prostate cancer; Colorectal cancer; Survival rate; Survival analysis; Gerontology; Oncology; Internal medicine; Environmental health","authors":[{"name":"Michel P. Coleman","is_ca":false},{"name":"Manuela Quaresma","is_ca":false},{"name":"Franco Berrino","is_ca":false},{"name":"Jean-Michel Lutz","is_ca":false},{"name":"Roberta De Angelis","is_ca":false},{"name":"Riccardo Capocaccia","is_ca":false},{"name":"Paolo Baili","is_ca":false},{"name":"Bernard Rachet","is_ca":false},{"name":"Gemma Gatta","is_ca":false},{"name":"Timo Hakulinen","is_ca":false},{"name":"Andrea Micheli","is_ca":false},{"name":"Milena Sant","is_ca":false},{"name":"Hannah K. Weir","is_ca":false},{"name":"Mark Elwood","is_ca":true},{"name":"Hideaki Tsukuma","is_ca":false},{"name":"Sérgio Koifman","is_ca":false},{"name":"Gulnar Azevedo e Silva","is_ca":false},{"name":"Silvia Francisci","is_ca":false},{"name":"Mariano Santaquilani","is_ca":false},{"name":"Arduino Verdecchia","is_ca":false},{"name":"Hans H. Storm","is_ca":false},{"name":"John L. Young","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1847457346792045,"gpt":0.4231636361772668,"spread":0.2384179014980623,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001405504,0.0005020041,0.0005561172,0.0022577,0.00110124,0.001055293,0.0008320759,0.000878851,0.0008895327],"category_scores_gemma":[0.001583181,0.0003078241,0.0007563024,0.00453967,0.0005498577,0.0008544262,0.001746639,0.000736097,0.0003063356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001711816,"about_ca_system_score_gemma":0.001502238,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1307363,"about_ca_topic_score_gemma":0.1598656,"domain_scores_codex":[0.9992023,0.0001705349,0.00008498982,0.0002562774,0.000118351,0.0001675044],"domain_scores_gemma":[0.9986233,0.0001150753,0.000453336,0.0002050144,0.0003069739,0.0002963344],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001008515,0.00003461861,0.9958099,0.00003248903,0.0001268363,0.0001590234,0.0003188187,0.00005372574,0.00007614624,0.00005127475,0.0008581076,0.00237819],"study_design_scores_gemma":[0.000008513559,0.00002938185,0.998695,0.00002608702,0.00003748007,0.0001225108,0.0002316967,0.00006608603,0.00001839081,0.0000120162,0.0007480659,0.000004855425],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935742,0.0009068621,0.0001274636,0.000186163,0.00001279362,0.00005936059,0.004026378,0.000008607211,0.001098218],"genre_scores_gemma":[0.9907217,0.0008385222,0.0003473455,0.0002632276,0.00002993988,0.00009507326,0.007268043,0.0000119429,0.0004241157],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1307363,"threshold_uncertainty_score":0.2599506,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2896600825","doi":"10.1016/s1470-2045(18)30700-9","title":"Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1409,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Ipilimumab; Nivolumab; Medicine; Internal medicine; Oncology; Immunotherapy; Cancer","authors":[{"name":"F. Stephen Hodi","is_ca":false},{"name":"Vanna Chiarion‐Sileni","is_ca":false},{"name":"René González","is_ca":false},{"name":"Jean-Jacques Grob","is_ca":false},{"name":"Piotr Rutkowski","is_ca":false},{"name":"C. Lance Cowey","is_ca":false},{"name":"Christopher D. Lao","is_ca":false},{"name":"Dirk Schadendorf","is_ca":false},{"name":"John Wagstaff","is_ca":false},{"name":"Reinhard Dummer","is_ca":false},{"name":"Pier Francesco Ferrucci","is_ca":false},{"name":"Michael Smylie","is_ca":false},{"name":"Andrew Hill","is_ca":false},{"name":"David Hogg","is_ca":true},{"name":"Iván Márquez‐Rodas","is_ca":false},{"name":"Joel Jiang","is_ca":false},{"name":"Jasmine I. Rizzo","is_ca":false},{"name":"James Larkin","is_ca":false},{"name":"Jedd D. Wolchok","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.059457284228469,"gpt":0.3855917897477813,"spread":0.3261345055193123,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003002837,0.001743852,0.002991277,0.000393988,0.0003877135,0.001412676,0.001170035,0.002018235,0.004666755],"category_scores_gemma":[0.002533619,0.0006652029,0.003564826,0.0003672662,0.001231366,0.001540654,0.0006387323,0.004321244,0.001026548],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001109391,"about_ca_system_score_gemma":0.0008640326,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001426132,"about_ca_topic_score_gemma":0.002850078,"domain_scores_codex":[0.9989017,0.0006663247,0.00004806115,0.0001735914,0.0000625976,0.0001475588],"domain_scores_gemma":[0.9986687,0.0005035638,0.0002844,0.0001151541,0.00005813583,0.0003701265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9841275,0.001945246,0.0005567081,0.0003754981,0.001489071,0.00002100971,0.00003956338,0.0003567301,0.001150996,0.00007194017,0.0006418975,0.009223809],"study_design_scores_gemma":[0.9468643,0.04830842,0.002498664,0.000044031,0.001052334,0.00002799777,0.00002794036,0.000361023,0.0002294098,0.0001761786,0.0003915267,0.00001819051],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869451,0.006883196,0.0004862803,0.0009162442,0.0006652562,0.00124222,0.000955089,0.0000996176,0.001807025],"genre_scores_gemma":[0.9902418,0.002380492,0.001053218,0.0009745004,0.0004235962,0.001079814,0.001107645,0.00003522572,0.002703754],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004666755,"threshold_uncertainty_score":0.0158807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2113344831","doi":"10.1016/s1470-2045(09)70314-6","title":"Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial","year":2009,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1405,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Genomic Health; U.S. Department of Health and Human Services","keywords":"Tamoxifen; Medicine; Internal medicine; Breast cancer; Oncology; Hazard ratio; Proportional hazards model; Anthracycline; Chemotherapy; Cyclophosphamide; Retrospective cohort study; Gynecology; Cancer; Confidence interval","authors":[{"name":"Kathy S. Albain","is_ca":false},{"name":"William E. Barlow","is_ca":false},{"name":"Steven Shak","is_ca":false},{"name":"Gabriel N. Hortobágyi","is_ca":false},{"name":"Robert B. Livingston","is_ca":false},{"name":"I‐Tien Yeh","is_ca":false},{"name":"Peter M. Ravdin","is_ca":false},{"name":"Roberto Bugarini","is_ca":false},{"name":"Frederick L. Baehner","is_ca":false},{"name":"Nancy E. Davidson","is_ca":false},{"name":"George W. Sledge","is_ca":false},{"name":"Eric P. Winer","is_ca":false},{"name":"Clifford A. Hudis","is_ca":false},{"name":"James N. Ingle","is_ca":false},{"name":"Edith A. Perez","is_ca":false},{"name":"Kathleen I. Pritchard","is_ca":true},{"name":"Lois E. Shepherd","is_ca":true},{"name":"Julie R. Gralow","is_ca":false},{"name":"Carl Yoshizawa","is_ca":false},{"name":"D. Craig Allred","is_ca":false},{"name":"C. Kent Osborne","is_ca":false},{"name":"Daniel F. Hayes","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008274236675616017,"gpt":0.2673977770089922,"spread":0.2591235403333762,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004676948,0.001050153,0.002228368,0.0003952024,0.0003892712,0.00128482,0.0008254644,0.001644526,0.001910372],"category_scores_gemma":[0.01021704,0.0006771284,0.002917081,0.0008909213,0.001542758,0.001041715,0.0005543203,0.001757682,0.0003112508],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007740223,"about_ca_system_score_gemma":0.0007611713,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001247607,"about_ca_topic_score_gemma":0.001500675,"domain_scores_codex":[0.9964113,0.002407831,0.000315736,0.00044383,0.0002221014,0.0001991919],"domain_scores_gemma":[0.9907137,0.005222095,0.002052582,0.00100192,0.0002875859,0.0007219974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9223838,0.0005018896,0.06047652,0.0003587223,0.005683722,0.00007068371,0.0001195597,0.0005201839,0.001307171,0.00009258886,0.0001910077,0.008294235],"study_design_scores_gemma":[0.5032617,0.1360102,0.3158547,0.0003140374,0.03412667,0.0005981029,0.0003361204,0.003279499,0.002177735,0.001365463,0.002448066,0.0002276938],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947183,0.004161738,0.0001407034,0.0001492474,0.0001056121,0.0001095255,0.0002479025,0.000006384371,0.0003606377],"genre_scores_gemma":[0.9983563,0.0007419164,0.0001378009,0.0001047716,0.00009240393,0.00007012425,0.0002898171,0.000003950733,0.0002029217],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004676948,"threshold_uncertainty_score":0.02473438,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168108459","doi":"10.1016/s1470-2045(12)70379-0","title":"Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study","year":2012,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1387,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; BC Cancer Agency","funders":"Janssen Research and Development; UCLH Biomedical Research Centre","keywords":"Abiraterone acetate; Medicine; Placebo; Prednisone; Prostate cancer; Clinical endpoint; Interim analysis; Internal medicine; Enzalutamide; Docetaxel; Population; Oncology; Androgen deprivation therapy; Clinical trial; Cancer; Androgen receptor; Pathology","authors":[{"name":"Karim Fizazi","is_ca":false},{"name":"Howard I. Scher","is_ca":false},{"name":"Arturo Molina","is_ca":false},{"name":"Christopher J. Logothetis","is_ca":false},{"name":"Kim N.","is_ca":true},{"name":"Robert J. Jones","is_ca":false},{"name":"John Staffurth","is_ca":false},{"name":"Scott North","is_ca":false},{"name":"Nicholas J. Vogelzang","is_ca":false},{"name":"Fred Saad","is_ca":true},{"name":"Paul N. Mainwaring","is_ca":false},{"name":"Stephen Harland","is_ca":false},{"name":"Oscar B. Goodman","is_ca":false},{"name":"Cora N. Sternberg","is_ca":false},{"name":"Jin Hui Li","is_ca":false},{"name":"Thian Kheoh","is_ca":false},{"name":"Christopher M. Haqq","is_ca":false},{"name":"Johann S. de Bono","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.187337688920738,"gpt":0.4545089135261337,"spread":0.2671712246053957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002663993,0.00190008,0.003537483,0.0006525494,0.0004670582,0.001228116,0.0008827086,0.001588456,0.00469738],"category_scores_gemma":[0.002572815,0.0006595561,0.003152893,0.0006870211,0.001525489,0.0009747409,0.0004144125,0.002915118,0.0008974103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007387291,"about_ca_system_score_gemma":0.001245197,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002008203,"about_ca_topic_score_gemma":0.00422779,"domain_scores_codex":[0.998769,0.0007841157,0.00007981049,0.0001174907,0.0001205775,0.0001290341],"domain_scores_gemma":[0.9981489,0.0007056774,0.0003927962,0.0002237041,0.00009717358,0.0004317415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.98699,0.001202461,0.0003298945,0.0004444844,0.0009753189,0.00002272708,0.00003316144,0.0002644972,0.001508781,0.0000430531,0.0003145562,0.00787115],"study_design_scores_gemma":[0.9526424,0.04186323,0.00306597,0.0000340606,0.001113774,0.00004727475,0.00002384562,0.0002823474,0.0002763102,0.0001749799,0.0004522688,0.00002364341],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9799986,0.01212848,0.0009932175,0.0005739984,0.000557118,0.001559082,0.001577385,0.0002240476,0.002388019],"genre_scores_gemma":[0.9889075,0.00486267,0.0008173855,0.0005930887,0.0004681344,0.0009306689,0.001055281,0.0000400379,0.002325229],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00469738,"threshold_uncertainty_score":0.01571429,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2753659610","doi":"10.1016/s1470-2045(17)30582-x","title":"Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care","year":2017,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":1382,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"Japanese Association of Cardiac Rehabilitation; L'Oreal USA","keywords":"Advance care planning; Delphi method; Delphi; Pooling; Palliative care; Health care; Process (computing); Adaptation (eye); Medicine; Nursing; Process management; Psychology; Medical education; Political science; Computer science; Business","authors":[{"name":"Judith Rietjens","is_ca":false},{"name":"Rebecca L. Sudore","is_ca":false},{"name":"Michael Connolly","is_ca":false},{"name":"Johannes J. M. van Delden","is_ca":false},{"name":"Margaret A. Drickamer","is_ca":false},{"name":"Mirjam Droger","is_ca":false},{"name":"Agnes van der Heide","is_ca":false},{"name":"Daren K. Heyland","is_ca":true},{"name":"Dirk Houttekier","is_ca":false},{"name":"Daisy J.A. Janssen","is_ca":false},{"name":"Luciano Orsi","is_ca":false},{"name":"Sheila Payne","is_ca":false},{"name":"Jane Seymour","is_ca":false},{"name":"Ralf J. Jox","is_ca":false},{"name":"Ida J. Korfage","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5513145969617606,"gpt":0.5722748071410236,"spread":0.02096021017926308,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03210877,0.002100014,0.004192872,0.008640088,0.001522587,0.007271168,0.006544632,0.006311915,0.005341832],"category_scores_gemma":[0.04015609,0.001107492,0.003569676,0.009512223,0.003740099,0.006868099,0.00658033,0.01189415,0.002028157],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00884549,"about_ca_system_score_gemma":0.03845304,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01056475,"about_ca_topic_score_gemma":0.0149952,"domain_scores_codex":[0.9893469,0.004114013,0.002665397,0.0007964293,0.002574866,0.0005023613],"domain_scores_gemma":[0.9713723,0.01913169,0.002724755,0.0005752358,0.005245254,0.0009506877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001379472,0.0001192935,0.0009236317,0.07630774,0.0003960404,0.0002656097,0.001755146,0.00155861,0.0002440274,0.05993371,0.1091059,0.7492524],"study_design_scores_gemma":[0.0001172646,0.00006729706,0.001339879,0.1577465,0.0007128804,0.0007545314,0.001317807,0.0004420595,0.0002556642,0.02548453,0.8116594,0.0001020875],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002265773,0.9561637,0.003443716,0.034227,0.002238623,0.0002041974,0.0003546774,0.00003384123,0.003107702],"genre_scores_gemma":[0.00463069,0.9615718,0.02019449,0.01080059,0.0008725619,0.0004716377,0.0007320084,0.00003111414,0.000695204],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03210877,"threshold_uncertainty_score":0.1698094,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2055346449","doi":"10.1016/s1470-2045(14)71205-7","title":"Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1354,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Janssen Research and Development","keywords":"Abiraterone acetate; Prednisone; Medicine; Prostate cancer; Placebo; Internal medicine; Oncology; Castration; Urology; Abiraterone; Enzalutamide; Cancer; Androgen deprivation therapy; Hormone; Androgen receptor; Pathology","authors":[{"name":"Charles J. Ryan","is_ca":false},{"name":"Matthew R. Smith","is_ca":false},{"name":"Karim Fizazi","is_ca":false},{"name":"Fred Saad","is_ca":true},{"name":"Peter F.A. Mulders","is_ca":false},{"name":"Cora N. Sternberg","is_ca":false},{"name":"Kurt Miller","is_ca":false},{"name":"Christopher J. Logothetis","is_ca":false},{"name":"Neal D. Shore","is_ca":false},{"name":"Eric J. Small","is_ca":false},{"name":"Joan Carles","is_ca":false},{"name":"Thomas W. Flaig","is_ca":false},{"name":"Mary-Ellen Taplin","is_ca":false},{"name":"Celestia S. Higano","is_ca":false},{"name":"Paul de Souza","is_ca":false},{"name":"Johann S. de Bono","is_ca":false},{"name":"Thomas W. Griffin","is_ca":false},{"name":"Peter De Porre","is_ca":false},{"name":"Margaret K. Yu","is_ca":false},{"name":"Youn C. Park","is_ca":false},{"name":"Jinhui Li","is_ca":false},{"name":"Thian Kheoh","is_ca":false},{"name":"Vahid Naini","is_ca":false},{"name":"Arturo Molina","is_ca":false},{"name":"Dana E. Rathkopf","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1589090600127682,"gpt":0.4258998720708133,"spread":0.2669908120580451,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002303499,0.001919901,0.00366889,0.0007445123,0.0004692406,0.001227529,0.001052096,0.001775616,0.004785404],"category_scores_gemma":[0.002228218,0.000850915,0.002714742,0.0006246045,0.001602116,0.00116557,0.0004503739,0.003089691,0.0009849538],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007269862,"about_ca_system_score_gemma":0.001102609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001923151,"about_ca_topic_score_gemma":0.00371099,"domain_scores_codex":[0.9991294,0.0005222476,0.00006140306,0.0001152437,0.0000640947,0.0001076304],"domain_scores_gemma":[0.9985648,0.0005399777,0.0002923773,0.0001240304,0.00006622555,0.0004126971],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9892036,0.00209019,0.0001714589,0.0003082028,0.0005066402,0.0000152984,0.00003347394,0.0002004411,0.001196743,0.00002815476,0.0001642574,0.006081481],"study_design_scores_gemma":[0.925648,0.07168847,0.001234106,0.00002230607,0.0005083923,0.00002302751,0.00002564413,0.0002571045,0.0002659917,0.0001131157,0.0001984419,0.00001538344],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882672,0.006663199,0.0005371831,0.0004613051,0.0005479255,0.001402064,0.0007098213,0.000171577,0.001239582],"genre_scores_gemma":[0.9910575,0.003549463,0.0007068522,0.0004590677,0.0004936255,0.0008654722,0.0005327034,0.00002793236,0.002307419],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004785404,"threshold_uncertainty_score":0.01600873,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2070825440","doi":"10.1016/s1470-2045(15)70122-1","title":"Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":1255,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Ipilimumab; Placebo; Medicine; Adjuvant; Oncology; Melanoma; Internal medicine; Stage (stratigraphy); Resection; Surgery; Cancer; Immunotherapy; Cancer research; Pathology","authors":[{"name":"Alexander M.M. Eggermont","is_ca":false},{"name":"Vanna Chiarion‐Sileni","is_ca":false},{"name":"Jean‐Jacques Grob","is_ca":false},{"name":"Reinhard Dummer","is_ca":false},{"name":"Jedd D. Wolchok","is_ca":false},{"name":"Henrik Schmidt","is_ca":false},{"name":"Omid Hamid","is_ca":false},{"name":"Caroline Robert","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false},{"name":"Jon Richards","is_ca":false},{"name":"Célèste Lebbé","is_ca":false},{"name":"Virginia Ferraresi","is_ca":false},{"name":"Michael Smylie","is_ca":true},{"name":"Jeffrey S. Weber","is_ca":false},{"name":"Michele Maio","is_ca":false},{"name":"Cyril Konto","is_ca":false},{"name":"Axel Hoos","is_ca":false},{"name":"Veerle de Pril","is_ca":false},{"name":"Ravichandra Karra Gurunath","is_ca":false},{"name":"Gaetan de Schaetzen","is_ca":false},{"name":"Stefan Suciu","is_ca":false},{"name":"Alessandro Testori","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1165948738888528,"gpt":0.3704590522131933,"spread":0.2538641783243404,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001993023,0.002541378,0.004826581,0.0005933294,0.0005385854,0.001435873,0.001238397,0.002437604,0.008890889],"category_scores_gemma":[0.001585758,0.00105985,0.002722472,0.0005308776,0.001715611,0.001453315,0.000577355,0.004327897,0.001838615],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009609409,"about_ca_system_score_gemma":0.001191981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001441163,"about_ca_topic_score_gemma":0.002300788,"domain_scores_codex":[0.9992923,0.0003288153,0.00003508508,0.0001450975,0.00004017409,0.0001585386],"domain_scores_gemma":[0.9991688,0.0002602693,0.0001813948,0.00006882993,0.00003944203,0.0002813556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9904242,0.002206098,0.00007775342,0.0003385847,0.0003237345,0.00001146355,0.00002033339,0.0001511293,0.0009082681,0.00004972273,0.0003700703,0.005118601],"study_design_scores_gemma":[0.9674887,0.03134043,0.0003531947,0.00002011014,0.0002004056,0.000009773281,0.000009053897,0.0001693009,0.0001197114,0.00008295406,0.0001968338,0.000009428751],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9771506,0.008274632,0.001433822,0.001128884,0.001756356,0.005426227,0.001385291,0.0003260288,0.003118211],"genre_scores_gemma":[0.9768289,0.004378559,0.001763385,0.001475357,0.000984208,0.006050042,0.001085358,0.00006190748,0.007372298],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008890889,"threshold_uncertainty_score":0.02974302,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2137935883","doi":"10.1016/s1470-2045(09)70262-1","title":"Ki67 in breast cancer: prognostic and predictive potential","year":2010,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1226,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Oncology; Medicine; Pathological; Oestrogen receptor; Internal medicine; Predictive marker; Cancer; Human Epidermal Growth Factor Receptor 2; Gynecology; Progesterone receptor; Bioinformatics; Estrogen receptor; Biology","authors":[{"name":"Rinat Yerushalmi","is_ca":true},{"name":"Ryan Woods","is_ca":true},{"name":"Peter M. Ravdin","is_ca":false},{"name":"Malcolm Hayes","is_ca":true},{"name":"Karen A. Gelmon","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0245620792448499,"gpt":0.3433855665218097,"spread":0.3188234872769598,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001494501,0.001081726,0.002137321,0.001853688,0.0001901314,0.001093712,0.001099297,0.001271063,0.001678402],"category_scores_gemma":[0.001852869,0.0004068905,0.0004615137,0.002785826,0.0008149496,0.001085644,0.0005631297,0.002221217,0.001361066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000995784,"about_ca_system_score_gemma":0.001292332,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00291651,"about_ca_topic_score_gemma":0.005656998,"domain_scores_codex":[0.9997239,0.00005084659,0.00003661015,0.00005750678,0.0001076636,0.00002356509],"domain_scores_gemma":[0.9987938,0.0007148323,0.0001379514,0.00003163412,0.000265719,0.00005587155],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001920976,0.00004015226,0.0006675625,0.007151485,0.0001582275,0.0001251489,0.00002166061,0.0003394879,0.0007012892,0.001851999,0.03427138,0.9544795],"study_design_scores_gemma":[0.000139488,0.0001883193,0.005640688,0.006174122,0.0006364608,0.00196873,0.0001174963,0.0002928363,0.0007784814,0.005817648,0.9781849,0.00006077766],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004980855,0.9992231,0.0000475784,0.0003085858,0.0001175662,0.000001156682,0.00001302396,0.000002381417,0.000236703],"genre_scores_gemma":[0.0006937692,0.9984021,0.0001236274,0.0002358155,0.0002895277,0.000002745774,0.00002140687,0.000001079732,0.000230065],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00291651,"threshold_uncertainty_score":0.007903755,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2557666746","doi":"10.1016/s1470-2045(16)30559-9","title":"Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1200,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"Cancer Research UK; Clovis Oncology; Ovarian Cancer Research Fund; Stand Up To Cancer; Healthway; U.S. Department of Defense; National Ovarian Cancer Coalition; Ovarian Cancer Research Fund Alliance; American Association for Cancer Research","keywords":"Open label; Oncology; Medicine; Internal medicine; Ovarian carcinoma; Platinum; Ovarian cancer; Clinical trial; Cancer; Chemistry","authors":[{"name":"Elizabeth M. Swisher","is_ca":false},{"name":"Kevin Lin","is_ca":false},{"name":"Amit M. Oza","is_ca":true},{"name":"Clare L. Scott","is_ca":false},{"name":"Heidi Giordano","is_ca":false},{"name":"James Sun","is_ca":false},{"name":"Gottfried E. Konecny","is_ca":false},{"name":"Robert L. Coleman","is_ca":false},{"name":"Anna V. Tinker","is_ca":true},{"name":"David M. O’Malley","is_ca":false},{"name":"Rebecca Kristeleit","is_ca":false},{"name":"Ling Ma","is_ca":false},{"name":"Katherine M. Bell‐McGuinn","is_ca":false},{"name":"James D. Brenton","is_ca":false},{"name":"Janiel M. Cragun","is_ca":false},{"name":"Ana Oaknin","is_ca":false},{"name":"Isabelle Ray‐Coquard","is_ca":false},{"name":"Maria I. Harrell","is_ca":false},{"name":"Elaina Mann","is_ca":false},{"name":"Scott H. Kaufmann","is_ca":false},{"name":"Anne Floquet","is_ca":false},{"name":"Alexandra Léary","is_ca":false},{"name":"Thomas C. Harding","is_ca":false},{"name":"Sandra Goble","is_ca":false},{"name":"Lara Maloney","is_ca":false},{"name":"Jeff Isaacson","is_ca":false},{"name":"Andrew R. Allen","is_ca":false},{"name":"Lindsey Rolfe","is_ca":false},{"name":"Roman Yelensky","is_ca":false},{"name":"Mitch Raponi","is_ca":false},{"name":"Iain A. McNeish","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1468834883678543,"gpt":0.4311228869311657,"spread":0.2842393985633114,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001909533,0.001609643,0.00255087,0.0003915906,0.0003098634,0.001237936,0.001014195,0.00162487,0.00538216],"category_scores_gemma":[0.001335877,0.0004909491,0.00176682,0.000427501,0.000804156,0.001336128,0.0004292531,0.004622358,0.001436219],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008122993,"about_ca_system_score_gemma":0.0008818129,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007909434,"about_ca_topic_score_gemma":0.002456791,"domain_scores_codex":[0.9995245,0.000211317,0.00001566193,0.00009241849,0.0000408014,0.0001154514],"domain_scores_gemma":[0.9993293,0.0001556494,0.0001106707,0.00007922612,0.00003442714,0.0002907613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7911469,0.02008582,0.002915731,0.00203434,0.003061134,0.0002713131,0.0002371805,0.00319819,0.01400797,0.0006323219,0.01104237,0.1513667],"study_design_scores_gemma":[0.8638442,0.1216533,0.005008267,0.00007965576,0.0007378084,0.0003404723,0.00006198061,0.001567659,0.001767188,0.0004324607,0.004457132,0.00004980301],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9757085,0.0117281,0.0009870726,0.001553231,0.0004880175,0.001767965,0.00268218,0.0004064905,0.004678438],"genre_scores_gemma":[0.9743536,0.005971343,0.00223648,0.00253569,0.0004154857,0.002053814,0.005393807,0.0001087022,0.006931029],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00538216,"threshold_uncertainty_score":0.01800507,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2726463501","doi":"10.1016/s1470-2045(17)30441-2","title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1192,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Notre-Dame; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Radiosurgery; Brain metastasis; Radiation therapy; Clinical endpoint; Randomized controlled trial; Surgery; Metastasis; Internal medicine; Cancer","authors":[{"name":"Paul D. Brown","is_ca":false},{"name":"Karla V. Ballman","is_ca":false},{"name":"Jane H. Cerhan","is_ca":false},{"name":"S. Keith Anderson","is_ca":false},{"name":"Xiomara W. Carrero","is_ca":false},{"name":"Anthony Whitton","is_ca":true},{"name":"Jeffrey Greenspoon","is_ca":true},{"name":"Ian F. Parney","is_ca":false},{"name":"Nadia N. Laack","is_ca":false},{"name":"Jonathan B. Ashman","is_ca":false},{"name":"Jean-Paul Bahary","is_ca":true},{"name":"Costas G. Hadjipanayis","is_ca":false},{"name":"James J. Urbanic","is_ca":false},{"name":"Fred G. Barker","is_ca":false},{"name":"Elana Farace","is_ca":false},{"name":"Deepak Khuntia","is_ca":false},{"name":"Caterina Giannini","is_ca":false},{"name":"Jan C. Buckner","is_ca":false},{"name":"Evanthia Galanis","is_ca":false},{"name":"David Roberge","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08135849473403658,"gpt":0.4090925863100155,"spread":0.327734091575979,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00145039,0.002191272,0.003377866,0.0003683604,0.0004671069,0.001093431,0.001162012,0.001759903,0.006652825],"category_scores_gemma":[0.001509394,0.0005646629,0.002916686,0.0005354653,0.001448624,0.0009576948,0.0004384178,0.003799426,0.001313851],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001008985,"about_ca_system_score_gemma":0.00125544,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002879843,"about_ca_topic_score_gemma":0.005705737,"domain_scores_codex":[0.9993395,0.0003483911,0.00003518451,0.0001210978,0.00005653568,0.00009929042],"domain_scores_gemma":[0.9993112,0.0002066551,0.0001836034,0.00006563017,0.0000420324,0.0001909338],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9850204,0.001945719,0.0002003337,0.0006218129,0.001067093,0.00001777137,0.00003457673,0.0002811853,0.001049467,0.00009574542,0.0008881849,0.008777719],"study_design_scores_gemma":[0.9567367,0.04065562,0.001009167,0.00004178341,0.0005714501,0.00002180908,0.00001954584,0.0002687736,0.0001706005,0.0001407232,0.0003500289,0.00001381448],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837539,0.006725391,0.000896632,0.0009343649,0.001061448,0.002802262,0.001214529,0.0001936458,0.002417978],"genre_scores_gemma":[0.9814525,0.004598213,0.001706475,0.001479801,0.0005578807,0.003582129,0.001472092,0.00006137749,0.005089514],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006652825,"threshold_uncertainty_score":0.02225596,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095826876","doi":"10.1016/s1470-2045(09)70334-1","title":"Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study","year":2009,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1187,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ipilimumab; Adverse effect; Clinical endpoint; Internal medicine; Melanoma; Clinical trial; Intention-to-treat analysis; Phases of clinical research; Randomized controlled trial; Gastroenterology; Surgery; Immunotherapy; Cancer","authors":[{"name":"Jedd D. Wolchok","is_ca":false},{"name":"Bart Neyns","is_ca":false},{"name":"Gerald P. Linette","is_ca":false},{"name":"Sylvie Négrier","is_ca":false},{"name":"Jose Lutzky","is_ca":false},{"name":"L. Thomas","is_ca":false},{"name":"William Waterfield","is_ca":false},{"name":"Dirk Schadendorf","is_ca":false},{"name":"Michael Smylie","is_ca":true},{"name":"Troy H. Guthrie","is_ca":false},{"name":"Jean‐Jacques Grob","is_ca":false},{"name":"Jason Chesney","is_ca":false},{"name":"Kevin M. Chin","is_ca":false},{"name":"Kun Chen","is_ca":false},{"name":"Axel Hoos","is_ca":false},{"name":"Steven O’Day","is_ca":false},{"name":"Célèste Lebbé","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03300815461349548,"gpt":0.3521155906350885,"spread":0.319107436021593,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002016576,0.002310963,0.004962175,0.0006056585,0.0005166639,0.001338097,0.0010525,0.002441659,0.0056446],"category_scores_gemma":[0.001656699,0.001240856,0.001833938,0.0007572002,0.001469574,0.001712346,0.0005779857,0.003744387,0.001444455],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007752011,"about_ca_system_score_gemma":0.001092387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000879898,"about_ca_topic_score_gemma":0.001389656,"domain_scores_codex":[0.9992082,0.0003692177,0.00004444033,0.0001663354,0.0000569312,0.0001549947],"domain_scores_gemma":[0.9990076,0.0002482396,0.0001949669,0.000117542,0.00005947424,0.0003722003],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9740831,0.008385796,0.000772359,0.0003182663,0.0005908835,0.00003380122,0.00005913021,0.0003239255,0.005098063,0.00003818953,0.0004028585,0.009893635],"study_design_scores_gemma":[0.9069921,0.08911771,0.0026323,0.00001261603,0.0003545155,0.00002278652,0.00001640088,0.0002174821,0.0002554864,0.00005641118,0.0003060573,0.00001604886],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929788,0.002140452,0.0004805416,0.0004178372,0.0003117535,0.001905016,0.000596108,0.00007542758,0.001094116],"genre_scores_gemma":[0.9878253,0.002428534,0.001279916,0.00119523,0.0005566459,0.002728543,0.001014069,0.00003600035,0.002935729],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0056446,"threshold_uncertainty_score":0.01888305,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2339311613","doi":"10.1016/s1470-2045(16)30033-x","title":"Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1175,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Ottawa Hospital; McGill University","funders":"European Society for Medical Oncology; Boehringer Ingelheim","keywords":"Afatinib; Gefitinib; Medicine; Internal medicine; Lung cancer; Oncology; Population; Clinical endpoint; Randomized controlled trial; Epidermal growth factor receptor; Cancer","authors":[{"name":"Keunchil Park","is_ca":false},{"name":"Eng-Huat Tan","is_ca":false},{"name":"Kenneth J. O’Byrne","is_ca":false},{"name":"Li Zhang","is_ca":false},{"name":"Michael Boyer","is_ca":false},{"name":"Tony Mok","is_ca":false},{"name":"Vera Hirsh","is_ca":true},{"name":"James Chih‐Hsin Yang","is_ca":false},{"name":"Ki Hyeong Lee","is_ca":false},{"name":"Shun Lü","is_ca":false},{"name":"Yuankai Shi","is_ca":false},{"name":"Sang-We Kim","is_ca":false},{"name":"Janessa Laskin","is_ca":true},{"name":"Dong‐Wan Kim","is_ca":false},{"name":"Catherine Dubos Arvis","is_ca":false},{"name":"Karl Kölbeck","is_ca":false},{"name":"Scott A. Laurie","is_ca":true},{"name":"Chun-Ming Tsai","is_ca":false},{"name":"Mehdi Shahidi","is_ca":false},{"name":"Miyoung Kim","is_ca":false},{"name":"Dan Massey","is_ca":false},{"name":"Victoria Zazulina","is_ca":false},{"name":"Luis Paz‐Ares","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04042620639566981,"gpt":0.4065506950648967,"spread":0.3661244886692269,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002021232,0.002557346,0.005699834,0.0005523631,0.0004880276,0.001678903,0.001400876,0.003170215,0.007954195],"category_scores_gemma":[0.002475582,0.0009701212,0.004581523,0.0004957592,0.001649494,0.002214848,0.0005165339,0.004764134,0.001521911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001114053,"about_ca_system_score_gemma":0.001117883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001262787,"about_ca_topic_score_gemma":0.002909564,"domain_scores_codex":[0.9989942,0.0005000847,0.00006712015,0.000202333,0.00006572564,0.0001705098],"domain_scores_gemma":[0.9990222,0.0003273113,0.0001981005,0.00007016165,0.00007132019,0.0003109092],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9862153,0.001657608,0.0002581927,0.0008598177,0.00129472,0.00003139125,0.000035167,0.0002842268,0.000832273,0.00008889875,0.0007185132,0.007723949],"study_design_scores_gemma":[0.976469,0.02175563,0.0004557736,0.00002785865,0.0004760611,0.00002749625,0.00001652364,0.0002559519,0.00009660816,0.000110761,0.0002953969,0.00001291374],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9680918,0.01771316,0.001035291,0.001978092,0.002107888,0.003588949,0.001848806,0.0003064121,0.00332953],"genre_scores_gemma":[0.9838048,0.005275236,0.001317965,0.00141851,0.0007005581,0.002538042,0.001333908,0.0000378046,0.003573262],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007954195,"threshold_uncertainty_score":0.02660948,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2136344041","doi":"10.1016/s1470-2045(14)70063-4","title":"Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1174,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Montreal General Hospital","funders":"Universität Duisburg-Essen; Aarhus Universitet; Universität zu Köln; Universitair Medisch Centrum Groningen; University College London; National Institute for Health and Care Research; Universitaire Ziekenhuizen Leuven, KU Leuven; Canadian Cancer Society Research Institute; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; EORTC Charitable Trust; Aarhus Universitetshospital; Cancer Research UK; Amgen","keywords":"Ifosfamide; Doxorubicin; Soft tissue sarcoma; Medicine; Sarcoma; Oncology; Soft tissue; Chemotherapy; Internal medicine; Surgery; Pathology; Cisplatin","authors":[{"name":"Ian Judson","is_ca":false},{"name":"Jaap Verweij","is_ca":false},{"name":"Hans Gelderblom","is_ca":false},{"name":"Jörg T. Hartmann","is_ca":false},{"name":"Patrick Schöffski","is_ca":false},{"name":"Jean‐Yves Blay","is_ca":false},{"name":"J. Martijn Kerst","is_ca":false},{"name":"Josef Sufliarsky","is_ca":false},{"name":"Jeremy Whelan","is_ca":false},{"name":"Peter Hohenberger","is_ca":false},{"name":"Anders Krarup‐Hansen","is_ca":false},{"name":"Thierry Alcindor","is_ca":true},{"name":"Sandrine Marréaud","is_ca":false},{"name":"Saskia Litière","is_ca":false},{"name":"C. Hermans","is_ca":false},{"name":"Cyril Fisher","is_ca":false},{"name":"Pancras C.W. Hogendoorn","is_ca":false},{"name":"Angelo Paolo Dei Tos","is_ca":false},{"name":"Winette T.A. van der Graaf","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1118737263595385,"gpt":0.4083463554134927,"spread":0.2964726290539542,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001813242,0.002452428,0.004398828,0.0005033711,0.0004450027,0.001439916,0.00132396,0.001970364,0.01072131],"category_scores_gemma":[0.002056045,0.0008570228,0.003101423,0.0005484429,0.001635195,0.001519416,0.0005883435,0.004808481,0.001586371],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001478287,"about_ca_system_score_gemma":0.001246007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002095214,"about_ca_topic_score_gemma":0.004038118,"domain_scores_codex":[0.9993131,0.0003291171,0.00003679981,0.0001529698,0.00003756484,0.0001304812],"domain_scores_gemma":[0.9989028,0.0003737055,0.0002310549,0.00009176801,0.00004988579,0.0003508443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9905619,0.001807534,0.0001245297,0.000428218,0.0006539993,0.00001788513,0.00003123142,0.0002774496,0.0008447748,0.00007018181,0.0003692692,0.004813063],"study_design_scores_gemma":[0.981092,0.01761984,0.0003802006,0.00002529432,0.0003124118,0.00001150404,0.00001061046,0.000151983,0.00008165729,0.00008992244,0.0002160265,0.000008595401],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9761396,0.00885469,0.001482109,0.00139975,0.00157867,0.005374189,0.001693648,0.0002193141,0.003258007],"genre_scores_gemma":[0.9771842,0.005348722,0.002221029,0.001593509,0.0006497792,0.005475054,0.001413146,0.00005972073,0.006054933],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01072131,"threshold_uncertainty_score":0.03586632,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2165413853","doi":"10.1016/s1470-2045(12)70425-4","title":"Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies","year":2012,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1159,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Child Health and Human Development; National Cancer Institute; Norwegian Institute of Public Health; University of California, San Francisco; University of North Carolina at Chapel Hill; Instituto Nacional De Salud Pública; Institut Gustave-Roussy; Wuhan University; Syddansk Universitet; Universidad de Costa Rica; Universitetet i Bergen; Odense Universitetshospital; Memorial Sloan-Kettering Cancer Center; Università degli Studi di Padova; Universiteit Maastricht; Imperial College London; World Health Organization; University of Southern California; University College London; Cancer Research UK; London School of Hygiene and Tropical Medicine; Loma Linda University; University of Otago; Shanghai Institute Of Planned Parenthood Research; Deutsches Krebsforschungszentrum; University of Pittsburgh; National and Kapodistrian University of Athens; Karolinska Institutet; Universidad de Chile; Institut National de la Santé et de la Recherche Médicale; University of Minnesota; Università degli Studi di Milano; University of Pennsylvania; Vanderbilt University; University of Toronto; National University of Singapore; Kaiser Permanente","keywords":"Menarche; Breast cancer; Epidemiology; Menopause; Medicine; Obstetrics; Gynecology; Cancer; Demography; Internal medicine; Sociology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.5872332569421976,"gpt":0.511669772123417,"spread":0.07556348481878061,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.01559064,0.002301571,0.009554827,0.002977181,0.0008322337,0.00266728,0.001756261,0.001995052,0.002965021],"category_scores_gemma":[0.02372167,0.002354247,0.03142408,0.00515623,0.000617331,0.001024305,0.001593549,0.002111735,0.0003423041],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008809793,"about_ca_system_score_gemma":0.001397074,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007448373,"about_ca_topic_score_gemma":0.008972161,"domain_scores_codex":[0.9887422,0.007065827,0.001847589,0.001306678,0.0007228936,0.0003149268],"domain_scores_gemma":[0.9862573,0.009747004,0.001659947,0.00131191,0.0007293687,0.0002944864],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.005908571,0.00002704202,0.03013305,0.01062426,0.9489987,0.000153234,0.00005156693,0.0006528268,0.0003379415,0.0000656281,0.0003886814,0.002658323],"study_design_scores_gemma":[0.001416575,0.0002803573,0.01602776,0.0008493398,0.9796333,0.0001382627,0.0000416981,0.0003505307,0.0001420535,0.0001638822,0.0009374311,0.00001873078],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2109633,0.7722677,0.007412789,0.0006906976,0.0006769511,0.0005566858,0.006083709,0.0002209666,0.001127175],"genre_scores_gemma":[0.9259663,0.06410598,0.004386869,0.0005967336,0.0001824007,0.0009828974,0.003023038,0.00008978564,0.0006660048],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9904452,"threshold_uncertainty_score":0.08245218,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2963476376","doi":"10.1016/s1470-2045(19)30388-2","title":"Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1153,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Merck Sharp and Dohme; Les Laboratories Pierre Fabre; Merck; Meso Scale Diagnostics; Roche; British Microcirculation Society; Amgen","keywords":"Ipilimumab; Pembrolizumab; Post-hoc analysis; Open label; Medicine; Post hoc; Oncology; Internal medicine; Clinical trial; Immunotherapy; Cancer","authors":[{"name":"Caroline Robert","is_ca":false},{"name":"Antoni Ribas","is_ca":false},{"name":"Jacob Schachter","is_ca":false},{"name":"Ana Arance","is_ca":false},{"name":"Jean‐Jacques Grob","is_ca":false},{"name":"Laurent Mortier","is_ca":false},{"name":"Adil Daud","is_ca":false},{"name":"Matteo S. Carlino","is_ca":false},{"name":"Catriona M. McNeil","is_ca":false},{"name":"Michal Lotem","is_ca":false},{"name":"James Larkin","is_ca":false},{"name":"Paul Lorigan","is_ca":false},{"name":"Bart Neyns","is_ca":false},{"name":"Christian U. Blank","is_ca":false},{"name":"Teresa M. Petrella","is_ca":true},{"name":"Omid Hamid","is_ca":false},{"name":"Shu-Chih Su","is_ca":false},{"name":"Clemens Krepler","is_ca":false},{"name":"Nageatte Ibrahim","is_ca":false},{"name":"Georgina V. Long","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04835099458072202,"gpt":0.3901170919169451,"spread":0.3417660973362231,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003135255,0.001882151,0.003397858,0.0004586636,0.0004253052,0.001381757,0.001120321,0.001658187,0.005906601],"category_scores_gemma":[0.002167792,0.0007157131,0.002810247,0.0004517135,0.001278678,0.001980364,0.0005299829,0.004250428,0.001205747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000877868,"about_ca_system_score_gemma":0.0008404616,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001196962,"about_ca_topic_score_gemma":0.002086209,"domain_scores_codex":[0.9989416,0.0006013688,0.00004960034,0.0001629677,0.00006922303,0.000175203],"domain_scores_gemma":[0.9987789,0.0004668239,0.0002785528,0.0001016975,0.00006208794,0.0003119513],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.983634,0.00272751,0.0002108085,0.0004216694,0.0007545332,0.00001867505,0.0000305821,0.0003089301,0.001573638,0.00005016556,0.0003689955,0.009900494],"study_design_scores_gemma":[0.934469,0.06183074,0.001931321,0.00003358276,0.0005731414,0.00002240121,0.00002399324,0.0003209599,0.0003059383,0.0001095999,0.0003644737,0.00001488106],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856907,0.006419362,0.0009340206,0.0006387478,0.0006134927,0.001980607,0.00128399,0.0001411258,0.002297976],"genre_scores_gemma":[0.9859838,0.0035911,0.001650907,0.001094808,0.0005304482,0.001894575,0.001375659,0.00004622949,0.003832437],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005906601,"threshold_uncertainty_score":0.0197596,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2749747068","doi":"10.1016/s1470-2045(17)30517-x","title":"Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1113,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Foothills Medical Centre; University of Calgary; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"Celldex Therapeutics","keywords":"Temozolomide; Medicine; Internal medicine; Clinical endpoint; Oncology; Progression-free survival; Phases of clinical research; Clinical trial; Chemotherapy; Surgery","authors":[{"name":"Michael Weller","is_ca":false},{"name":"Nicholas Butowski","is_ca":false},{"name":"David Tran","is_ca":false},{"name":"Lawrence D. Recht","is_ca":false},{"name":"Michael Lim","is_ca":false},{"name":"Hal W. Hirte","is_ca":true},{"name":"Lynn S. Ashby","is_ca":false},{"name":"Laszlo Mechtler","is_ca":false},{"name":"Samuel Goldlust","is_ca":false},{"name":"Fábio M. Iwamoto","is_ca":false},{"name":"Jan Drappatz","is_ca":false},{"name":"Donald M. O’Rourke","is_ca":false},{"name":"Mark Wong","is_ca":false},{"name":"Mark G. Hamilton","is_ca":true},{"name":"Gaetano Finocchiaro","is_ca":false},{"name":"James Perry","is_ca":true},{"name":"Wolfgang Wick","is_ca":false},{"name":"Jennifer Green","is_ca":false},{"name":"Yi He","is_ca":false},{"name":"Christopher D. Turner","is_ca":false},{"name":"Michael Yellin","is_ca":false},{"name":"Tibor Keler","is_ca":false},{"name":"Thomas A. Davis","is_ca":false},{"name":"Roger Stupp","is_ca":false},{"name":"John H. Sampson","is_ca":false},{"name":"Jian Campian","is_ca":false},{"name":"Kevin Becker","is_ca":false},{"name":"Gene H. Barnett","is_ca":false},{"name":"Garth Nicholas","is_ca":false},{"name":"Annick Desjardins","is_ca":false},{"name":"Tara Benkers","is_ca":false},{"name":"Naveed Wagle","is_ca":false},{"name":"Morris D. Groves","is_ca":false},{"name":"Santosh Kesari","is_ca":false},{"name":"Zsolt Horváth","is_ca":false},{"name":"Ryan Merrell","is_ca":false},{"name":"Richard Curry","is_ca":false},{"name":"James O’Rourke","is_ca":false},{"name":"David M. Schuster","is_ca":false},{"name":"Maciej M. Mrugała","is_ca":false},{"name":"Randy Jensen","is_ca":false},{"name":"John Trusheim","is_ca":false},{"name":"Glenn J. Lesser","is_ca":false},{"name":"Karl Bélanger","is_ca":false},{"name":"Andrew E. Sloan","is_ca":false},{"name":"Benjamin Purow","is_ca":false},{"name":"Karen Fink","is_ca":false},{"name":"Jeffrey J. Raizer","is_ca":false},{"name":"Michael Schulder","is_ca":false},{"name":"Suresh Nair","is_ca":false},{"name":"Scott Peak","is_ca":false},{"name":"Alba A. Brandes","is_ca":false},{"name":"Nimish Mohile","is_ca":false},{"name":"Joseph Landolfi","is_ca":false},{"name":"Jon Olson","is_ca":false},{"name":"Ross Jennens","is_ca":false},{"name":"Paul DeSouza","is_ca":false},{"name":"Bridget A. Robinson","is_ca":false},{"name":"Marka R. Crittenden","is_ca":false},{"name":"Kent C. Shih","is_ca":false},{"name":"Alexandra Flowers","is_ca":false},{"name":"Shirley Ong","is_ca":false},{"name":"Jennifer Connelly","is_ca":false},{"name":"Costas G. Hadjipanayis","is_ca":false},{"name":"Pierre Giglio","is_ca":false},{"name":"Frank E. Mott","is_ca":false},{"name":"David Mathieu","is_ca":false},{"name":"N. Lessard","is_ca":false},{"name":"Sanchez Juan Sepulveda","is_ca":false},{"name":"József Lövey","is_ca":false},{"name":"Helen Wheeler","is_ca":false},{"name":"Po-Ling Inglis","is_ca":false},{"name":"Claire Hardie","is_ca":false},{"name":"Daniela A. Bota","is_ca":false},{"name":"Maciej S. Lesniak","is_ca":false},{"name":"Jana Portnow","is_ca":false},{"name":"Bruce Frankel","is_ca":false},{"name":"Larry Junck","is_ca":false},{"name":"Reid C. Thompson","is_ca":false},{"name":"Lawrence Berk","is_ca":false},{"name":"John Paul McGhie","is_ca":false},{"name":"David Macdonald","is_ca":false},{"name":"Frank Saran","is_ca":false},{"name":"Riccardo Soffietti","is_ca":false},{"name":"Deborah T. Blumenthal","is_ca":false},{"name":"Sá Barreto Costa Marcos André de","is_ca":false},{"name":"Anna K. Nowak","is_ca":false},{"name":"Nimit Singhal","is_ca":false},{"name":"Andreas F. Hottinger","is_ca":false},{"name":"Andrea Schmid","is_ca":false},{"name":"Gordan Srkalović","is_ca":false},{"name":"David S. Baskin","is_ca":false},{"name":"Camilo E. Fadul","is_ca":false},{"name":"Burt Nabors","is_ca":false},{"name":"Renato V. LaRocca","is_ca":false},{"name":"John L. Villano","is_ca":false},{"name":"Nina A. Paleologos","is_ca":false},{"name":"Petr Kavan","is_ca":false},{"name":"Marshall Pitz","is_ca":false},{"name":"Brian Thiessen","is_ca":false},{"name":"Ahmed Idbaïh","is_ca":false},{"name":"Jean‐Sébastien Frenel","is_ca":false},{"name":"Julien Dômont","is_ca":false},{"name":"Oliver Grauer","is_ca":false},{"name":"Peter Hau","is_ca":false},{"name":"Christine Marosi","is_ca":false},{"name":"Jan Šroubek","is_ca":false},{"name":"Elizabeth Hovey","is_ca":false},{"name":"P.S. Sridhar","is_ca":false},{"name":"Lawrence Cher","is_ca":false},{"name":"Erin Dunbar","is_ca":false},{"name":"Thomas Coyle","is_ca":false},{"name":"Jane M. Raymond","is_ca":false},{"name":"Kevin Barton","is_ca":false},{"name":"Michael J. Guarino","is_ca":false},{"name":"Sumul Raval","is_ca":false},{"name":"Baldassarre Stea","is_ca":false},{"name":"J. Richard Dietrich","is_ca":false},{"name":"Kirsten Hopkins","is_ca":false},{"name":"Sara Erridge","is_ca":false},{"name":"Joachim-Peter Steinbach","is_ca":false},{"name":"Losada Estela Pineda","is_ca":false},{"name":"Barco Berron Sonia del","is_ca":false},{"name":"M. Wenczl","is_ca":false},{"name":"Katalin Molnár","is_ca":false},{"name":"Katalin Hidéghety","is_ca":false},{"name":"Alexander Lossos","is_ca":false},{"name":"Linde Myra van","is_ca":false},{"name":"Ana Levy","is_ca":false},{"name":"Rosemary Harrup","is_ca":false},{"name":"William P. Patterson","is_ca":false},{"name":"Zarnie Lwin","is_ca":false},{"name":"Sith Sathornsumetee","is_ca":false},{"name":"E-Jian Lee","is_ca":false},{"name":"Jih-Tsun Ho","is_ca":false},{"name":"Steven Emmons","is_ca":false},{"name":"J. Paul Duic","is_ca":false},{"name":"Spencer H. Shao","is_ca":false},{"name":"Hani Ashamalla","is_ca":false},{"name":"Michael Weaver","is_ca":false},{"name":"Jose Lutzky","is_ca":false},{"name":"Nicholas G. Avgeropoulos","is_ca":false},{"name":"Wahid T. Hanna","is_ca":false},{"name":"Mukund Nadipuram","is_ca":false},{"name":"G Cecchi","is_ca":false},{"name":"Robert D. O’Donnell","is_ca":false},{"name":"Susan C. Pannullo","is_ca":false},{"name":"Jennifer Carney","is_ca":false},{"name":"Mark Hamilton","is_ca":true},{"name":"Mary MacNeil","is_ca":false},{"name":"R. P. Beaney","is_ca":false},{"name":"Michel Fabbro","is_ca":false},{"name":"Oliver Schnell","is_ca":false},{"name":"Rainer Fietkau","is_ca":false},{"name":"Guenther Stockhammer","is_ca":false},{"name":"Běla Malinová","is_ca":false},{"name":"Karel Odrážka","is_ca":false},{"name":"Martin Sameš","is_ca":false},{"name":"Gil Miguel Gil","is_ca":false},{"name":"E. Razis","is_ca":false},{"name":"Konstantin Lavrenkov","is_ca":false},{"name":"Guillermo Castro","is_ca":false},{"name":"Francisco Ramirez","is_ca":false},{"name":"Clarissa Baldotto","is_ca":false},{"name":"Fabiana Viola","is_ca":false},{"name":"Suzana Mária Fleury Malheiros","is_ca":false},{"name":"Jason D. Lickliter","is_ca":false},{"name":"Stanislaw J. Gauden","is_ca":false},{"name":"Arunee Dechaphunkul","is_ca":false},{"name":"Iyavut Thaipisuttikul","is_ca":false},{"name":"Ziad Thotathil","is_ca":false},{"name":"Hsin‐I Ma","is_ca":false},{"name":"Wen-Yu Cheng","is_ca":false},{"name":"Chin-Hong Chang","is_ca":false},{"name":"Fernando Palacios Salas","is_ca":false},{"name":"Pierre‐Yves Dietrich","is_ca":false},{"name":"Christoph Mamot","is_ca":false},{"name":"Lakshmi Nayak","is_ca":false},{"name":"Shona Nag","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05302134748243224,"gpt":0.3716507209685209,"spread":0.3186293734860886,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001363688,0.001907974,0.002451013,0.0003810292,0.0003648341,0.00105627,0.000880116,0.001578662,0.005076693],"category_scores_gemma":[0.001313519,0.0006673981,0.001982558,0.000414418,0.001146988,0.001410437,0.0004148679,0.003505762,0.0009995507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009673343,"about_ca_system_score_gemma":0.001074302,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001616977,"about_ca_topic_score_gemma":0.003768841,"domain_scores_codex":[0.9994853,0.000265686,0.00002397419,0.00009241874,0.00003180156,0.000100856],"domain_scores_gemma":[0.9995232,0.0001200478,0.0001085539,0.00004237868,0.00003118562,0.0001746459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9780198,0.002385694,0.0003420846,0.0005581848,0.001144928,0.00003449463,0.00006025329,0.0003747041,0.001779356,0.0001667977,0.001193869,0.01393978],"study_design_scores_gemma":[0.9692444,0.0281151,0.0009651184,0.00003027696,0.0003424995,0.00002897687,0.00002319058,0.000250502,0.0002093895,0.0002126388,0.0005641372,0.00001376391],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843622,0.006408061,0.0008136383,0.0009604316,0.0008516316,0.002494646,0.001012895,0.0001824761,0.00291418],"genre_scores_gemma":[0.9845253,0.003833538,0.001443393,0.00118313,0.0003779765,0.002827035,0.001112664,0.00003956804,0.004657405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005076693,"threshold_uncertainty_score":0.01698327,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117964602","doi":"10.1016/s1470-2045(11)70214-5","title":"Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1113,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Juravinski Cancer Centre; Vancouver General Hospital; Hôtel-Dieu de Montréal; Centre Hospitalier de l’Université de Montréal; Université de Montréal; BC Cancer Agency; Princess Margaret Cancer Centre; Jewish General Hospital","funders":"AstraZeneca","keywords":"Medicine; Olaparib; Internal medicine; Tolerability; Breast cancer; Ovarian cancer; Oncology; BRCA mutation; PARP inhibitor; Clinical endpoint; Triple-negative breast cancer; Adverse effect; Response Evaluation Criteria in Solid Tumors; Cancer; Serous fluid; Phases of clinical research; Clinical trial","authors":[{"name":"Karen A. Gelmon","is_ca":true},{"name":"Marc Tischkowitz","is_ca":true},{"name":"Helen Mackay","is_ca":true},{"name":"Kenneth D. Swenerton","is_ca":true},{"name":"André Robidoux","is_ca":true},{"name":"Katia Tonkin","is_ca":false},{"name":"Hal W. Hirte","is_ca":true},{"name":"David G. Huntsman","is_ca":true},{"name":"Mark Clemons","is_ca":true},{"name":"C. Blake Gilks","is_ca":true},{"name":"Rinat Yerushalmi","is_ca":true},{"name":"Euan Macpherson","is_ca":false},{"name":"James Carmichael","is_ca":false},{"name":"Amit M. Oza","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1110609224459381,"gpt":0.3838345029660907,"spread":0.2727735805201525,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001518688,0.00164626,0.003119019,0.0003678015,0.0003383737,0.001309311,0.0006725653,0.001515906,0.002947871],"category_scores_gemma":[0.002001887,0.000702781,0.002391229,0.0005405281,0.001074727,0.001339738,0.0004801437,0.002680496,0.000673212],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000652259,"about_ca_system_score_gemma":0.000742389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007898663,"about_ca_topic_score_gemma":0.001385797,"domain_scores_codex":[0.9992493,0.0004014163,0.00005028744,0.0001283676,0.00005859277,0.0001120569],"domain_scores_gemma":[0.9990572,0.0003467516,0.0002043744,0.00009641634,0.00004252171,0.0002526743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.968868,0.003447413,0.002909726,0.0006636194,0.001586037,0.0001128347,0.00008157673,0.0004786997,0.00261835,0.00006752579,0.000528466,0.0186378],"study_design_scores_gemma":[0.9204349,0.06985808,0.006698267,0.00003693797,0.001100742,0.0001336994,0.00005471263,0.0004784024,0.0002872969,0.0001777412,0.0007094108,0.00002987268],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927713,0.004122259,0.0003686535,0.0004076777,0.0002114368,0.0006877633,0.0006363013,0.00004401532,0.0007503881],"genre_scores_gemma":[0.992995,0.002809852,0.0005907576,0.0007372315,0.0002237249,0.0007170221,0.0008505413,0.00001586107,0.001060071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003119019,"threshold_uncertainty_score":0.009861588,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2145376545","doi":"10.1016/s1470-2045(15)70057-4","title":"Response assessment criteria for brain metastases: proposal from the RANO group","year":2015,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1088,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; Queen's University; London Health Sciences Centre; Ontario Institute for Cancer Research","funders":"Breast Cancer Research Foundation","keywords":"Group (periodic table); Computer science; Medicine; Medical physics; Psychology; Physics","authors":[{"name":"Nancy U. Lin","is_ca":false},{"name":"Eudocia Q. Lee","is_ca":false},{"name":"Hidefumi Aoyama","is_ca":false},{"name":"Igor J. Barani","is_ca":false},{"name":"Daniel P. Barboriak","is_ca":false},{"name":"Brigitta G. Baumert","is_ca":false},{"name":"Martin Bendszus","is_ca":false},{"name":"Paul D. Brown","is_ca":false},{"name":"D. Ross Camidge","is_ca":false},{"name":"Susan M. Chang","is_ca":false},{"name":"Janet Dancey","is_ca":true},{"name":"Elisabeth G.E. de Vries","is_ca":false},{"name":"Laurie E. Gaspar","is_ca":false},{"name":"Gordon J. Harris","is_ca":false},{"name":"F. Stephen Hodi","is_ca":false},{"name":"Steven N. Kalkanis","is_ca":false},{"name":"Mark E. Linskey","is_ca":false},{"name":"David Macdonald","is_ca":true},{"name":"Kim Margolin","is_ca":false},{"name":"Minesh P. Mehta","is_ca":false},{"name":"David Schiff","is_ca":false},{"name":"Riccardo Soffietti","is_ca":false},{"name":"John H. Suh","is_ca":false},{"name":"Martin J. van den Bent","is_ca":false},{"name":"Michael A. Vogelbaum","is_ca":false},{"name":"Patrick Y. Wen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2039613437360562,"gpt":0.5016602951475275,"spread":0.2976989514114713,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02108623,0.001578375,0.007723272,0.00330447,0.0005276484,0.002593846,0.004500144,0.00345763,0.002536276],"category_scores_gemma":[0.02187469,0.0005228943,0.006902266,0.002505857,0.001460691,0.002436247,0.002217249,0.007651092,0.001327561],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005133356,"about_ca_system_score_gemma":0.006837597,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005753042,"about_ca_topic_score_gemma":0.00777157,"domain_scores_codex":[0.9933129,0.003075184,0.001645509,0.0004784248,0.001197424,0.0002906779],"domain_scores_gemma":[0.9860663,0.009570378,0.00132665,0.0002492268,0.002494764,0.0002927058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001907303,0.0001239964,0.001287775,0.06265285,0.002376577,0.0001624897,0.0003117055,0.00146648,0.0009376156,0.01482413,0.08362829,0.8303208],"study_design_scores_gemma":[0.004314798,0.001017982,0.01027928,0.119661,0.01144883,0.001293923,0.0003723288,0.002034149,0.001257759,0.02336602,0.82464,0.0003141483],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"methods","genre_scores_codex":[0.0006224182,0.9772564,0.002883607,0.01396274,0.002064621,0.0005263257,0.0005911437,0.000051119,0.002041569],"genre_scores_gemma":[0.02215049,0.9080924,0.02752312,0.02968675,0.003462141,0.003914141,0.002230095,0.0001101316,0.002830744],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.02108623,"threshold_uncertainty_score":0.111516,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2536769127","doi":"10.1016/s1470-2045(16)30532-0","title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1086,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"London Health Sciences Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center","keywords":"Medicine; Oncology; Maintenance therapy; Clinical endpoint; Internal medicine; Systemic therapy; Radiation therapy; Lung cancer; Performance status; Progression-free survival; Targeted therapy; Chemotherapy; Cancer; Randomized controlled trial","authors":[{"name":"Daniel R. Gomez","is_ca":false},{"name":"George R. Blumenschein","is_ca":false},{"name":"Mike Hernández","is_ca":false},{"name":"Rong Ye","is_ca":false},{"name":"D. Ross Camidge","is_ca":false},{"name":"Robert C. Doebele","is_ca":false},{"name":"Ferdinandos Skoulidis","is_ca":false},{"name":"Laurie E. Gaspar","is_ca":false},{"name":"Don L. Gibbons","is_ca":false},{"name":"José A. Karam","is_ca":false},{"name":"Brian D. Kavanagh","is_ca":false},{"name":"Chad Tang","is_ca":false},{"name":"Ritsuko Komaki","is_ca":false},{"name":"Alexander V. Louie","is_ca":true},{"name":"David A. Palma","is_ca":true},{"name":"Anne S. Tsao","is_ca":false},{"name":"Boris Sepesi","is_ca":false},{"name":"William N. William","is_ca":false},{"name":"Jianjun Zhang","is_ca":false},{"name":"Qiuling Shi","is_ca":false},{"name":"Xin Shelley Wang","is_ca":false},{"name":"Stephen G. Swisher","is_ca":false},{"name":"John V. Heymach","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0456415097933536,"gpt":0.3758414789814968,"spread":0.3301999691881432,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001586878,0.001871428,0.004294298,0.0004996448,0.0004166591,0.001034762,0.001331744,0.001675165,0.006299231],"category_scores_gemma":[0.001494561,0.000634796,0.002420502,0.0005964703,0.001572687,0.00135576,0.0005622909,0.003536446,0.0009625495],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001128915,"about_ca_system_score_gemma":0.001024631,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001951909,"about_ca_topic_score_gemma":0.00452255,"domain_scores_codex":[0.9992839,0.0003340253,0.00003571594,0.0001666427,0.00004822285,0.0001315075],"domain_scores_gemma":[0.9990329,0.0003037464,0.0002001337,0.00008700896,0.00005449879,0.0003217719],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9845746,0.004203704,0.0003232183,0.000419379,0.0005371881,0.00001625559,0.00004353297,0.0002222298,0.001260476,0.00003880723,0.0002809825,0.008079618],"study_design_scores_gemma":[0.9265781,0.07057539,0.001746663,0.00002345888,0.0003828584,0.00001394618,0.0000242116,0.0002334634,0.0001554127,0.00006640294,0.0001899326,0.0000101847],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920008,0.003291339,0.0004318644,0.0003609992,0.0004344399,0.001783347,0.000579542,0.0000763659,0.001041256],"genre_scores_gemma":[0.9904528,0.002039376,0.0009460812,0.0005734758,0.0003589086,0.002285937,0.0007793574,0.00002561087,0.002538429],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006299231,"threshold_uncertainty_score":0.02107304,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2164437838","doi":"10.1016/s1470-2045(15)00222-3","title":"Expanding global access to radiotherapy","year":2015,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":1085,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; Princess Margaret Cancer Centre; University of Toronto; Queen's University; University Health Network","funders":"World Health Organization","keywords":"Radiation therapy; Low and middle income countries; Middle income; Developed country; Developing country; Medicine; Business; Economic growth; Economics; Environmental health; Demographic economics; Surgery; Population","authors":[{"name":"Rifat Atun","is_ca":false},{"name":"David A. Jaffray","is_ca":true},{"name":"Michael Bartoň","is_ca":false},{"name":"Freddie Bray","is_ca":false},{"name":"Michaël Baumann","is_ca":false},{"name":"Bhadrasain Vikram","is_ca":false},{"name":"Timothy P. Hanna","is_ca":true},{"name":"Felícia Marie Knaul","is_ca":false},{"name":"Yolande Lievens","is_ca":false},{"name":"Tracey Y M Lui","is_ca":true},{"name":"Michael Milosevic","is_ca":true},{"name":"Brian O’Sullivan","is_ca":true},{"name":"Danielle Rodin","is_ca":true},{"name":"Eduardo Rosenblatt","is_ca":false},{"name":"Jacob Van Dyk","is_ca":true},{"name":"Mei Ling Yap","is_ca":false},{"name":"Eduardo Zubizarreta","is_ca":false},{"name":"Mary Gospodarowicz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.20159668286846,"gpt":0.5736985221372256,"spread":0.3721018392687656,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001105178,0.0008131937,0.001252735,0.002090425,0.0002745039,0.001345461,0.0007167008,0.00152613,0.01384041],"category_scores_gemma":[0.002436384,0.000292456,0.0005921436,0.002454098,0.0007674576,0.002535165,0.001827812,0.00231843,0.002398748],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001501224,"about_ca_system_score_gemma":0.002385078,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002206998,"about_ca_topic_score_gemma":0.005993227,"domain_scores_codex":[0.9996129,0.0001110588,0.00004607579,0.00004520284,0.0001247291,0.00006006391],"domain_scores_gemma":[0.9991168,0.0004900163,0.0001515524,0.00002279327,0.0001377312,0.00008114166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006850615,0.00002549854,0.0001862915,0.0203413,0.00009076887,0.0001186819,0.00007045255,0.0003769349,0.000386639,0.008182505,0.08853053,0.8816218],"study_design_scores_gemma":[0.00002503855,0.00002841881,0.0005202968,0.007717678,0.00008572773,0.0004112555,0.00007052356,0.00005088111,0.00008030397,0.003074763,0.9879246,0.00001048906],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004728938,0.996394,0.00006781156,0.001390755,0.0003762973,0.000002570153,0.00002148114,0.000006206674,0.001693586],"genre_scores_gemma":[0.0007006713,0.9968939,0.00009385979,0.001188721,0.0005219226,0.000003641922,0.0000289329,0.000002160887,0.0005661852],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01384041,"threshold_uncertainty_score":0.04630077,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2142875113","doi":"10.1016/s1470-2045(07)70278-4","title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","year":2007,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1078,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Saint John Regional Hospital; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Axillary Lymph Node Dissection; Sentinel lymph node; Breast cancer; Surgery; Lymph node; Stage (stratigraphy); Randomized controlled trial; Dissection (medical); Cancer; Internal medicine","authors":[{"name":"David N. Krag","is_ca":false},{"name":"Stewart Anderson","is_ca":false},{"name":"Thomas B. Julian","is_ca":false},{"name":"Ann Brown","is_ca":false},{"name":"Seth P. Harlow","is_ca":false},{"name":"Takamaru Ashikaga","is_ca":false},{"name":"Donald L. Weaver","is_ca":false},{"name":"Bárbara Miller","is_ca":false},{"name":"Lynne M Jalovec","is_ca":false},{"name":"Thomas G. Frazier","is_ca":false},{"name":"R. Dirk Noyes","is_ca":false},{"name":"André Robidoux","is_ca":true},{"name":"Hugh MC Scarth","is_ca":true},{"name":"Denise Mammolito","is_ca":false},{"name":"David R. McCready","is_ca":true},{"name":"Eleftherios P. Mamounas","is_ca":false},{"name":"Joseph P. Costantino","is_ca":false},{"name":"Norman Wolmark","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02027302097998062,"gpt":0.3380045078926205,"spread":0.3177314869126399,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00305745,0.001634736,0.002120995,0.0002977971,0.0002391586,0.0009847939,0.0008784705,0.00147087,0.002276901],"category_scores_gemma":[0.002884848,0.0005212603,0.002601462,0.0004446047,0.001372348,0.001292462,0.0005732704,0.002574135,0.0003989652],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00109281,"about_ca_system_score_gemma":0.001111148,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001200601,"about_ca_topic_score_gemma":0.002453427,"domain_scores_codex":[0.9986928,0.0008348118,0.00007253209,0.0001629425,0.0001004487,0.0001364482],"domain_scores_gemma":[0.9979683,0.0007564154,0.0005707132,0.0002003008,0.00006841419,0.0004358843],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9760429,0.001372649,0.005290538,0.000315129,0.001694044,0.0000297207,0.0000443979,0.0009838087,0.001166623,0.0001141884,0.0005996883,0.01234629],"study_design_scores_gemma":[0.8023469,0.1327576,0.05631967,0.0001259967,0.003442004,0.0001433496,0.0001496964,0.001351195,0.0009441843,0.00109507,0.001254901,0.00006945468],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919127,0.004886359,0.0002611144,0.0006559938,0.0002509727,0.000201577,0.0006152699,0.00002140869,0.001194586],"genre_scores_gemma":[0.9944994,0.00184663,0.0003605805,0.0005629989,0.0002767785,0.0002759328,0.001077784,0.0000153702,0.001084404],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00305745,"threshold_uncertainty_score":0.01616955,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2973153606","doi":"10.1016/s1470-2045(19)30456-5","title":"Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1052,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; Nova Scotia Health Authority; Government of New Brunswick; Canadian Partnership Against Cancer; Dr. H. Bliss Murphy Cancer Centre; Saskatchewan Cancer Agency; CancerCare Manitoba; Cancer Care Ontario; Alberta Health Services","funders":"Department of Health, Government of Western Australia; Public Health Agency; Cancer Council Victoria; Partenariat Canadien Contre Le Cancer; Cancer Society of New Zealand; Cancer Institute NSW; Kreftforeningen; Cancer Research UK; World Health Organization; Cancer Focus Northern Ireland; Northern Ireland Environment Agency; Kræftens Bekæmpelse; Scottish Government","keywords":"Medicine; Cancer; Population; Colorectal cancer; Incidence (geometry); Demography; Cancer registry; Lung cancer; Stomach cancer; Environmental health; Oncology; Internal medicine","authors":[{"name":"Melina Arnold","is_ca":false},{"name":"Mark J. Rutherford","is_ca":false},{"name":"Aude Bardot","is_ca":false},{"name":"Jacques Ferlay","is_ca":false},{"name":"Therése Andersson","is_ca":false},{"name":"Tor Åge Myklebust","is_ca":false},{"name":"Hanna Tervonen","is_ca":false},{"name":"Vicky Thursfield","is_ca":false},{"name":"David Ransom","is_ca":false},{"name":"Lorraine Shack","is_ca":true},{"name":"Ryan Woods","is_ca":false},{"name":"Donna Turner","is_ca":true},{"name":"Suzanne Leonfellner","is_ca":true},{"name":"Susan Ryan","is_ca":true},{"name":"Nathalie Saint‐Jacques","is_ca":true},{"name":"Prithwish De","is_ca":true},{"name":"Carol McClure","is_ca":false},{"name":"Agnihotram V. Ramanakumar","is_ca":true},{"name":"H. Stuart-Panko","is_ca":true},{"name":"Gerda Engholm","is_ca":false},{"name":"Paul M. Walsh","is_ca":false},{"name":"Christopher Jackson","is_ca":false},{"name":"Sally Vernon","is_ca":false},{"name":"Eileen Morgan","is_ca":false},{"name":"Anna Gavin","is_ca":false},{"name":"David Morrison","is_ca":false},{"name":"Dyfed Huws","is_ca":false},{"name":"Geoff Porter","is_ca":true},{"name":"John Butler","is_ca":false},{"name":"Heather Bryant","is_ca":true},{"name":"David C. Currow","is_ca":false},{"name":"Sara Hiom","is_ca":false},{"name":"D. Max Parkin","is_ca":false},{"name":"Peter Sasieni","is_ca":false},{"name":"Paul C. Lambert","is_ca":false},{"name":"Bjørn Møller","is_ca":false},{"name":"Isabelle Soerjomataram","is_ca":false},{"name":"Freddie Bray","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1223546848596375,"gpt":0.4346419930388014,"spread":0.3122873081791639,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002094179,0.0008462726,0.0008439911,0.002530341,0.000639947,0.001670424,0.001184122,0.0009875355,0.001145857],"category_scores_gemma":[0.002885601,0.0008456552,0.001660585,0.007244592,0.0006704179,0.001258909,0.002053492,0.001354545,0.0005627917],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001501066,"about_ca_system_score_gemma":0.001518962,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.09152083,"about_ca_topic_score_gemma":0.07997507,"domain_scores_codex":[0.9985569,0.0003661996,0.0002312404,0.0003384384,0.0002050219,0.0003021503],"domain_scores_gemma":[0.9979844,0.0002258938,0.0007242527,0.0002333331,0.0004626834,0.0003693762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002171904,0.0000455292,0.9964913,0.0000356874,0.0003103651,0.0000573949,0.0002439321,0.0001575924,0.0000659682,0.00003692376,0.001047195,0.001291119],"study_design_scores_gemma":[0.00001945246,0.00005685143,0.9985906,0.00001448031,0.0001382757,0.00006804582,0.0004899844,0.00008220215,0.00003305389,0.00001086002,0.0004871443,0.000008962543],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9773357,0.0006140939,0.000204057,0.0001459876,0.00002702954,0.00004449768,0.02069103,0.00002208642,0.0009155817],"genre_scores_gemma":[0.976087,0.0004822168,0.0002141905,0.0000962796,0.00002621301,0.0001125514,0.02240666,0.00001574971,0.0005592761],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09152083,"threshold_uncertainty_score":0.1819763,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2113322173","doi":"10.1016/s1470-2045(12)70559-4","title":"External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1029,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Health Sciences Centre; Western University; Sunnybrook Health Science Centre; University of Calgary","funders":"National Cancer Institute","keywords":"Renal cell carcinoma; Medicine; Prognostic model; Population; Oncology; Database; Internal medicine; Computer science; Overall survival; Environmental health","authors":[{"name":"Daniel Y.C. Heng","is_ca":true},{"name":"Wanling Xie","is_ca":false},{"name":"Meredith M. Regan","is_ca":false},{"name":"Lauren C. Harshman","is_ca":false},{"name":"Georg A. Bjarnason","is_ca":true},{"name":"Ulka N. Vaishampayan","is_ca":false},{"name":"Mary J. MacKenzie","is_ca":true},{"name":"Lori Wood","is_ca":true},{"name":"Frede Donskov","is_ca":false},{"name":"Min-Han Tan","is_ca":false},{"name":"Sun Young Rha","is_ca":false},{"name":"Neeraj Agarwal","is_ca":false},{"name":"Christian Kollmannsberger","is_ca":true},{"name":"Brian I. Rini","is_ca":false},{"name":"Toni K. Choueiri","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08719604319912287,"gpt":0.3307886472917002,"spread":0.2435926040925773,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07331189,0.002097959,0.001861522,0.001458728,0.00146698,0.002468323,0.004223462,0.002224792,0.002901785],"category_scores_gemma":[0.1041429,0.0007127037,0.004319543,0.001833885,0.002162599,0.002295182,0.003012643,0.003854349,0.001362796],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00120274,"about_ca_system_score_gemma":0.001660466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00490867,"about_ca_topic_score_gemma":0.003438163,"domain_scores_codex":[0.9667055,0.02607272,0.001059971,0.003687873,0.00180611,0.0006677452],"domain_scores_gemma":[0.8761141,0.08684473,0.005304778,0.02157718,0.008752376,0.001406803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02747341,0.003338465,0.9077989,0.0002956432,0.01236177,0.0003742533,0.00142987,0.01838748,0.0009831417,0.001139339,0.007636236,0.01878147],"study_design_scores_gemma":[0.007916396,0.009058295,0.8277296,0.0002756634,0.01060333,0.001392353,0.001691835,0.1275252,0.001459352,0.004743157,0.007325727,0.0002791523],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869731,0.0003179095,0.008055788,0.0002213431,0.0001058853,0.0002295457,0.003309384,0.00007270669,0.0007143982],"genre_scores_gemma":[0.9882224,0.00009748443,0.002191419,0.00011236,0.00006727705,0.000276339,0.008614427,0.0001088464,0.0003094602],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07331189,"threshold_uncertainty_score":0.387715,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2161689638","doi":"10.1016/s1470-2045(11)70175-9","title":"Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1028,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Hepatocellular carcinoma; Liver transplantation; Transplantation; Consensus conference; Listing (finance); Donation; Family medicine; Internal medicine; Political science; Law","authors":[{"name":"Pierre-Alain Clavien","is_ca":false},{"name":"Mickaël Lesurtel","is_ca":false},{"name":"Patrick M. Bossuyt","is_ca":false},{"name":"Gregory J. Gores","is_ca":false},{"name":"Bernard Langer","is_ca":true},{"name":"Arnaud Perrier","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3238269917420179,"gpt":0.3579941574896356,"spread":0.03416716574761769,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06249036,0.002067844,0.004388741,0.005280172,0.002395413,0.005936008,0.008308311,0.01257943,0.004109369],"category_scores_gemma":[0.06170029,0.001592133,0.006992016,0.005252562,0.002161393,0.003536241,0.005768626,0.02160977,0.002453726],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01007778,"about_ca_system_score_gemma":0.03750879,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02242166,"about_ca_topic_score_gemma":0.02729938,"domain_scores_codex":[0.9746713,0.008184456,0.007735594,0.001253579,0.006718817,0.00143634],"domain_scores_gemma":[0.9376003,0.02027259,0.009296869,0.001233306,0.02456361,0.007033399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004864784,0.0003930966,0.008645077,0.01647791,0.001825134,0.0005289914,0.001532539,0.001850267,0.0007698703,0.006017952,0.6793438,0.282129],"study_design_scores_gemma":[0.002440577,0.0003023983,0.02059841,0.08940832,0.006263988,0.0009200365,0.003569636,0.001689128,0.001227769,0.01268377,0.8605329,0.0003631335],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.003423323,0.1882808,0.01102331,0.7446026,0.03321229,0.002032617,0.003041001,0.0002805664,0.01410355],"genre_scores_gemma":[0.07209703,0.3621649,0.1747092,0.3265628,0.01977473,0.009039726,0.01787584,0.0005460455,0.01722975],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.06249036,"threshold_uncertainty_score":0.3304846,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2101922439","doi":"10.1016/s1470-2045(14)70379-1","title":"Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":1019,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Merck KGaA","keywords":"Temozolomide; Medicine; Chemoradiotherapy; Internal medicine; Oncology; Clinical endpoint; Phases of clinical research; Progression-free survival; Clinical trial; Chemotherapy","authors":[{"name":"Roger Stupp","is_ca":false},{"name":"Monika E. Hegi","is_ca":false},{"name":"Thierry Gorlia","is_ca":false},{"name":"Sara Erridge","is_ca":false},{"name":"James Perry","is_ca":true},{"name":"Yong-Kil Hong","is_ca":false},{"name":"Kenneth Aldape","is_ca":false},{"name":"Benoît Lhermitte","is_ca":false},{"name":"Torsten Pietsch","is_ca":false},{"name":"Danica Grujičić","is_ca":false},{"name":"Joachim P. Steinbach","is_ca":false},{"name":"Wolfgang Wick","is_ca":false},{"name":"R. Tarnawski","is_ca":false},{"name":"Do‐Hyun Nam","is_ca":false},{"name":"Peter Hau","is_ca":false},{"name":"Astrid Weyerbrock","is_ca":false},{"name":"Chiung‐Chyi Shen","is_ca":false},{"name":"Nalini Rao","is_ca":false},{"name":"László Thurzó","is_ca":false},{"name":"Ulrich Herrlinger","is_ca":false},{"name":"Tejpal Gupta","is_ca":false},{"name":"Rolf‐Dieter Kortmann","is_ca":false},{"name":"Krystyna Adamska","is_ca":false},{"name":"Catherine McBain","is_ca":false},{"name":"Alba A. Brandes","is_ca":false},{"name":"J. C. Tonn","is_ca":false},{"name":"Oliver Schnell","is_ca":false},{"name":"Thomas Wiegel","is_ca":false},{"name":"Chae‐Yong Kim","is_ca":false},{"name":"Burt Nabors","is_ca":false},{"name":"David A. Reardon","is_ca":false},{"name":"Martin J. van den Bent","is_ca":false},{"name":"Christine Hicking","is_ca":false},{"name":"Andriy Markivskyy","is_ca":false},{"name":"Martin Picard","is_ca":false},{"name":"Michael Weller","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04591526199650049,"gpt":0.3746563513188675,"spread":0.3287410893223671,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001130289,0.001782487,0.003503492,0.0005193014,0.0003790272,0.00110101,0.001091098,0.001831337,0.005201884],"category_scores_gemma":[0.001114259,0.0006250493,0.002240949,0.0005650118,0.001162942,0.001325924,0.000421594,0.003533505,0.001176138],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001046928,"about_ca_system_score_gemma":0.0009761634,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002050369,"about_ca_topic_score_gemma":0.005602174,"domain_scores_codex":[0.9996365,0.0001578988,0.00001535498,0.00007779164,0.00002650225,0.00008599294],"domain_scores_gemma":[0.9995667,0.0001047696,0.00008374877,0.0000353784,0.00002869936,0.0001806756],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9714835,0.00326861,0.000654049,0.000798471,0.001416544,0.00004641497,0.00004863319,0.0004560852,0.001858758,0.000166483,0.002031298,0.01777118],"study_design_scores_gemma":[0.9486884,0.04710636,0.001976666,0.00004823815,0.0006028507,0.00003279429,0.00003386041,0.0003469911,0.0001963249,0.0002028264,0.0007456295,0.00001892147],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9814263,0.009244174,0.0006676135,0.001382723,0.001123554,0.001749939,0.001548238,0.0001936491,0.002663754],"genre_scores_gemma":[0.9820936,0.005045438,0.001371364,0.001981345,0.0005969268,0.002048497,0.002611091,0.00004268125,0.004208999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005201884,"threshold_uncertainty_score":0.01740199,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2804105316","doi":"10.1016/s1470-2045(18)30292-4","title":"Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1011,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"Astex Pharmaceuticals; Novartis","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Hormone receptor; Endocrine system; Hormone therapy; Gynecology; Cancer; Hormone","authors":[{"name":"Debu Tripathy","is_ca":false},{"name":"Seock‐Ah Im","is_ca":false},{"name":"Marco Colleoni","is_ca":false},{"name":"Fábio Franke","is_ca":false},{"name":"Aditya Bardia","is_ca":false},{"name":"Nadia Harbeck","is_ca":false},{"name":"Sara A. Hurvitz","is_ca":false},{"name":"Louis W.C. Chow","is_ca":false},{"name":"Joohyuk Sohn","is_ca":false},{"name":"Keun Seok Lee","is_ca":false},{"name":"Saúl Campos-Gómez","is_ca":false},{"name":"Rafael Villanueva-Vázquez","is_ca":false},{"name":"Kyung Hae Jung","is_ca":false},{"name":"Govind Babu","is_ca":false},{"name":"Paul Wheatley‐Price","is_ca":true},{"name":"Michelino De Laurentiis","is_ca":false},{"name":"Young‐Hyuck Im","is_ca":false},{"name":"Sherko Küemmel","is_ca":false},{"name":"Nagi S. El-Saghir","is_ca":false},{"name":"Mei-Ching Liu","is_ca":false},{"name":"Gary P. Carlson","is_ca":false},{"name":"Gareth Hughes","is_ca":false},{"name":"Iván Díaz-Padilla","is_ca":false},{"name":"Caroline Germa","is_ca":false},{"name":"Samit Hirawat","is_ca":false},{"name":"Yen‐Shen Lu","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03244725651231038,"gpt":0.3715379082167767,"spread":0.3390906517044663,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00128093,0.001520973,0.002249221,0.0003647828,0.0003501467,0.001013981,0.0009013261,0.00171137,0.01081094],"category_scores_gemma":[0.001387945,0.0005725081,0.002418379,0.0003809478,0.0009553131,0.0008610016,0.0005038374,0.003252038,0.001952367],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008575195,"about_ca_system_score_gemma":0.001091216,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001872325,"about_ca_topic_score_gemma":0.006678168,"domain_scores_codex":[0.9996374,0.0001801997,0.00001473805,0.0000571874,0.00002735649,0.00008304657],"domain_scores_gemma":[0.9995239,0.0001369125,0.00007237974,0.00004567555,0.00002789953,0.0001933247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9638402,0.003143784,0.0006164248,0.001054655,0.001732935,0.00006409686,0.00006090074,0.0004692136,0.002447357,0.0002248183,0.003085553,0.02325999],"study_design_scores_gemma":[0.9682809,0.02804646,0.001207702,0.00004412474,0.0005235228,0.00004311722,0.00002651235,0.0001890975,0.0001237519,0.0001958062,0.001306857,0.00001219068],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9504369,0.02539359,0.0008993712,0.003009056,0.001753179,0.005027988,0.004235759,0.0003420038,0.008901997],"genre_scores_gemma":[0.9533215,0.01319192,0.001962294,0.004401722,0.0009019407,0.006029165,0.005059229,0.00007789171,0.01505444],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01081094,"threshold_uncertainty_score":0.03616619,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111404068","doi":"10.1016/s1470-2045(14)70012-9","title":"Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":978,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Medical Research Council; National Health and Medical Research Council; National Cancer Institute; National Institutes of Health; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Genentech; F. Hoffmann-La Roche","keywords":"Vemurafenib; Dacarbazine; Medicine; Internal medicine; Melanoma; Population; Oncology; Progression-free survival; Metastatic melanoma; Chemotherapy; Cancer research; Cancer","authors":[{"name":"Grant A. McArthur","is_ca":false},{"name":"Paul B. Chapman","is_ca":false},{"name":"Caroline Robert","is_ca":false},{"name":"James Larkin","is_ca":false},{"name":"John B.A.G. Haanen","is_ca":false},{"name":"Reinhard Dummer","is_ca":false},{"name":"Antoni Ribas","is_ca":false},{"name":"David Hogg","is_ca":true},{"name":"Omid Hamid","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false},{"name":"Claus Garbe","is_ca":false},{"name":"Alessandro Testori","is_ca":false},{"name":"Michele Maio","is_ca":false},{"name":"Paul Lorigan","is_ca":false},{"name":"Célèste Lebbé","is_ca":false},{"name":"Thomas Jouary","is_ca":false},{"name":"Dirk Schadendorf","is_ca":false},{"name":"S. O'Day","is_ca":false},{"name":"John M. Kirkwood","is_ca":false},{"name":"Alexander M.M. Eggermont","is_ca":false},{"name":"Brigitte Dréno","is_ca":false},{"name":"Jeffrey A. Sosman","is_ca":false},{"name":"Keith T. Flaherty","is_ca":false},{"name":"Ming Yin","is_ca":false},{"name":"Ivor Caro","is_ca":false},{"name":"Suzanne Cheng","is_ca":false},{"name":"Kerstin Trunzer","is_ca":false},{"name":"Axel Hauschild","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0286159142605539,"gpt":0.3339014764236995,"spread":0.3052855621631456,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003949154,0.001826263,0.003658735,0.0004176501,0.0004627716,0.001810358,0.001102231,0.002035602,0.003582321],"category_scores_gemma":[0.002927694,0.0008570632,0.003841465,0.0004780108,0.001255677,0.002123655,0.0004808018,0.004416535,0.001153335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001321256,"about_ca_system_score_gemma":0.0009583288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009440455,"about_ca_topic_score_gemma":0.001521477,"domain_scores_codex":[0.9987283,0.0006131897,0.00006362491,0.0001620243,0.0001274831,0.0003054112],"domain_scores_gemma":[0.9979856,0.0005695259,0.0004997528,0.0002264808,0.0001319271,0.0005866196],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9567642,0.003857563,0.002038258,0.0004802949,0.001854866,0.00007925976,0.00008827834,0.0008627842,0.005060294,0.00008658344,0.001124001,0.02770358],"study_design_scores_gemma":[0.8063305,0.1664794,0.0206879,0.00007640621,0.001679424,0.0002263101,0.0000783322,0.0009554772,0.001380702,0.0004578911,0.001575633,0.00007200619],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916729,0.004752457,0.0004626338,0.0004093361,0.0001912818,0.0004646235,0.000985936,0.00008585576,0.0009748869],"genre_scores_gemma":[0.9937229,0.001502167,0.0004907216,0.000620322,0.0002330184,0.0006096335,0.001358075,0.00003562452,0.001427588],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003949154,"threshold_uncertainty_score":0.02088535,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2560704457","doi":"10.1016/s1470-2045(16)30624-6","title":"Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":961,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital; Princess Margaret Cancer Centre; Juravinski Cancer Centre; University of Toronto; McMaster University","funders":"National Cancer Institute; University of Oxford","keywords":"Nivolumab; Ipilimumab; Medicine; Tolerability; Internal medicine; Lung cancer; Oncology; Cancer; Surgery; Adverse effect; Immunotherapy","authors":[{"name":"Matthew D. Hellmann","is_ca":false},{"name":"Naiyer A. Rizvi","is_ca":false},{"name":"Jonathan W. Goldman","is_ca":false},{"name":"Scott Gettinger","is_ca":false},{"name":"Hossein Borghaei","is_ca":false},{"name":"Julie R. Brahmer","is_ca":false},{"name":"Neal Ready","is_ca":false},{"name":"David E. Gerber","is_ca":false},{"name":"Laura Q.M. Chow","is_ca":false},{"name":"Rosalyn A. Juergens","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Scott A. Laurie","is_ca":true},{"name":"William J. Geese","is_ca":false},{"name":"Shruti Agrawal","is_ca":false},{"name":"Tina C. Young","is_ca":false},{"name":"Xuemei Li","is_ca":false},{"name":"Scott Antonia","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08906368332496893,"gpt":0.4350249849294019,"spread":0.345961301604433,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003734068,0.001981157,0.002731945,0.0004913421,0.0005290761,0.001676163,0.001058406,0.001672437,0.002763827],"category_scores_gemma":[0.002551839,0.0009486742,0.002949941,0.0005631314,0.001110814,0.001782045,0.0004508407,0.002918649,0.0008367244],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001219717,"about_ca_system_score_gemma":0.001175039,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001634911,"about_ca_topic_score_gemma":0.003121032,"domain_scores_codex":[0.9987181,0.0007443323,0.00005133091,0.000244088,0.0001049757,0.0001371151],"domain_scores_gemma":[0.9984348,0.0005133307,0.0003188884,0.0002228401,0.000103837,0.0004062736],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9481148,0.01428009,0.00541743,0.0005415175,0.003687005,0.00006380218,0.00009134047,0.0009180941,0.003694024,0.00006050598,0.001008125,0.02212324],"study_design_scores_gemma":[0.7826654,0.186597,0.02123707,0.00005828284,0.005404721,0.000148791,0.0001095884,0.001369185,0.001143418,0.0001666496,0.001032748,0.0000672618],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947753,0.002128334,0.0003072507,0.0002028134,0.0001569618,0.0006818435,0.0009991815,0.00006421207,0.0006840279],"genre_scores_gemma":[0.993687,0.001407067,0.0008652543,0.0005887907,0.0002065228,0.0005838005,0.001584747,0.00003320241,0.001043635],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003734068,"threshold_uncertainty_score":0.01974785,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2121847974","doi":"10.1016/s1470-2045(15)70127-0","title":"Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":955,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Bevacizumab; FOLFIRI; Ramucirumab; Medicine; Oxaliplatin; Oncology; Internal medicine; Colorectal cancer; Second-line therapy; Placebo; Chemotherapy; Overall survival; Cancer; Pathology","authors":[{"name":"Josep Tabernero","is_ca":false},{"name":"Takayuki Yoshino","is_ca":false},{"name":"Allen Lee Cohn","is_ca":false},{"name":"Radka Obermannová","is_ca":false},{"name":"G. Bodoky","is_ca":false},{"name":"Rocio García‐Carbonero","is_ca":false},{"name":"Tudor–Eliade Ciuleanu","is_ca":false},{"name":"David C. Portnoy","is_ca":false},{"name":"Eric Van Cutsem","is_ca":false},{"name":"Axel Grothey","is_ca":false},{"name":"Jana Prausová","is_ca":false},{"name":"Pilar García‐Alfonso","is_ca":false},{"name":"Kentaro Yamazaki","is_ca":false},{"name":"Philip R. Clingan","is_ca":false},{"name":"Sara Lonardi","is_ca":false},{"name":"Tae Won Kim","is_ca":false},{"name":"Lorinda Simms","is_ca":true},{"name":"Shao-Chun Chang","is_ca":false},{"name":"Federico Nasroulah","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09086894514201639,"gpt":0.3537783983077336,"spread":0.2629094531657172,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002070412,0.002038846,0.00483002,0.0006030865,0.0004173464,0.001317689,0.001087958,0.001863766,0.003193644],"category_scores_gemma":[0.001695952,0.001007077,0.002957509,0.0004703534,0.001025974,0.001545831,0.0004215138,0.003710777,0.0007649325],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000934109,"about_ca_system_score_gemma":0.0009033749,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00114289,"about_ca_topic_score_gemma":0.002649689,"domain_scores_codex":[0.9991757,0.0004282208,0.00005232747,0.0001462486,0.00004481807,0.0001526881],"domain_scores_gemma":[0.9991936,0.0002245014,0.0001944329,0.0000759707,0.00004690429,0.0002645896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.981985,0.004130179,0.0003976224,0.0003377922,0.0007898417,0.00002854925,0.00004986785,0.0002283368,0.001815134,0.00003342692,0.0002489949,0.009955158],"study_design_scores_gemma":[0.8600777,0.1354023,0.002375284,0.00002691849,0.0007393245,0.00004086699,0.00003224092,0.0004282811,0.0004730174,0.00006676002,0.0003147224,0.00002257684],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920056,0.004682973,0.0002975839,0.0003582068,0.000444338,0.0008280145,0.0003014934,0.0001018623,0.0009798459],"genre_scores_gemma":[0.9942497,0.001778046,0.0006662597,0.000438061,0.0003494186,0.0006369009,0.0003741067,0.00001609198,0.001491356],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00483002,"threshold_uncertainty_score":0.01094949,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152905269","doi":"10.1016/s1470-2045(12)70087-6","title":"Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial","year":2012,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":953,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Afatinib; Medicine; Erlotinib; Gefitinib; Internal medicine; Clinical endpoint; Hazard ratio; Placebo; Lung cancer; Oncology; Performance status; Chemotherapy; Adenocarcinoma; Randomized controlled trial; Surgery; Cancer; Epidermal growth factor receptor; Confidence interval; Pathology","authors":[{"name":"Vincent A. Miller","is_ca":false},{"name":"Vera Hirsh","is_ca":true},{"name":"Jacques Cadranel","is_ca":false},{"name":"Yuh-Min Chen","is_ca":false},{"name":"Keunchil Park","is_ca":false},{"name":"Sang-We Kim","is_ca":false},{"name":"Caicun Zhou","is_ca":false},{"name":"Wu‐Chou Su","is_ca":false},{"name":"Mengzhao Wang","is_ca":false},{"name":"Yan Sun","is_ca":false},{"name":"Dae Seog Heo","is_ca":false},{"name":"Lucio Crinò","is_ca":false},{"name":"Eng-Huat Tan","is_ca":false},{"name":"Tsu-Yi Chao","is_ca":false},{"name":"Mehdi Shahidi","is_ca":false},{"name":"Xiuyu Julie Cong","is_ca":false},{"name":"Robert M. Lorence","is_ca":false},{"name":"James Chih‐Hsin Yang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03765453655497886,"gpt":0.403575366148624,"spread":0.3659208295936452,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001970906,0.002389709,0.005274345,0.0005748309,0.0005625978,0.001466907,0.001067507,0.003178598,0.008294312],"category_scores_gemma":[0.002467905,0.0008116649,0.004036337,0.0005327513,0.001764522,0.00217747,0.0005861023,0.004395033,0.001597802],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008511507,"about_ca_system_score_gemma":0.0008813021,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009586675,"about_ca_topic_score_gemma":0.001782435,"domain_scores_codex":[0.9990678,0.000450717,0.00007865146,0.0001942424,0.000044376,0.0001641996],"domain_scores_gemma":[0.9990797,0.000308523,0.0001829571,0.00007266788,0.00005260613,0.0003034547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9891192,0.001189731,0.0002088018,0.0005034719,0.0008368677,0.00003129557,0.00003335799,0.0002082355,0.0008754985,0.00008423895,0.000461633,0.006447704],"study_design_scores_gemma":[0.9740978,0.02423607,0.0004443209,0.00002277399,0.0003513021,0.00002696649,0.00001835227,0.0001926261,0.0001178844,0.0001945024,0.0002853753,0.00001211033],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9738818,0.01284208,0.000881224,0.002446824,0.002175529,0.002925971,0.001443496,0.0002542336,0.00314881],"genre_scores_gemma":[0.9884259,0.003068747,0.0007828276,0.001243061,0.0006336986,0.001741018,0.0006707364,0.00002475732,0.003409344],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008294312,"threshold_uncertainty_score":0.02774727,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106285196","doi":"10.1016/s1470-2045(10)70223-0","title":"External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study","year":2010,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":944,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"Ligue Contre le Cancer; AstraZeneca; American Society for Radiation Oncology","keywords":"Medicine; Goserelin; Androgen suppression; Prostate cancer; Clinical endpoint; Urology; Cyproterone acetate; Radiation therapy; Androgen; Prostate; Antiandrogen; Internal medicine; Androgen deprivation therapy; Randomized controlled trial; Medroxyprogesterone acetate; Cancer; Surgery; Hormone","authors":[{"name":"M. Bolla","is_ca":false},{"name":"Geertjan van Tienhoven","is_ca":false},{"name":"Padraig Warde","is_ca":true},{"name":"J.B. Dubois","is_ca":false},{"name":"René‐Olivier Mirimanoff","is_ca":false},{"name":"Guy Storme","is_ca":false},{"name":"Jacques Bernier","is_ca":false},{"name":"Abraham Kuten","is_ca":false},{"name":"Cora N. Sternberg","is_ca":false},{"name":"Ignace Billiet","is_ca":false},{"name":"José Lopez Torecilla","is_ca":false},{"name":"Raphael Pfeffer","is_ca":false},{"name":"Carmel Lino Cutajar","is_ca":false},{"name":"Theodorus van der Kwast","is_ca":true},{"name":"Laurence Collette","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03438830034005187,"gpt":0.3603229668372296,"spread":0.3259346664971777,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005687158,0.002548305,0.006014866,0.0005898451,0.0006539442,0.001756462,0.001746912,0.00338985,0.006207016],"category_scores_gemma":[0.004227511,0.001298584,0.006652088,0.0009218547,0.002788193,0.002034334,0.001135219,0.004807021,0.001061342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00168207,"about_ca_system_score_gemma":0.001451105,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004328316,"about_ca_topic_score_gemma":0.004943518,"domain_scores_codex":[0.9960893,0.002486961,0.0002086713,0.0004831866,0.0002171712,0.0005146693],"domain_scores_gemma":[0.9962443,0.001675792,0.000674123,0.0005817298,0.0001502279,0.0006739296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9936004,0.001380799,0.000471407,0.0001943986,0.001131436,0.00002036756,0.00002713793,0.0001734845,0.000561777,0.00003108571,0.0001231993,0.002284662],"study_design_scores_gemma":[0.9420749,0.04884421,0.00554946,0.00004848908,0.002564418,0.00003407426,0.00004260794,0.0001574233,0.0002172019,0.0001411591,0.0002985069,0.00002746456],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900584,0.005205099,0.0006440997,0.0004570156,0.0005119981,0.0007573515,0.001015884,0.0000572212,0.001292994],"genre_scores_gemma":[0.9906289,0.003031108,0.0005831242,0.0007025818,0.0005047662,0.0007270939,0.00105909,0.00004650978,0.002716789],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006207016,"threshold_uncertainty_score":0.03007692,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2415950182","doi":"10.1016/s1470-2045(16)30107-3","title":"Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":939,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Exelixis; Memorial Sloan-Kettering Cancer Center","keywords":"Cabozantinib; Everolimus; Meteor (satellite); Renal cell carcinoma; Medicine; Open label; Oncology; Internal medicine; Clinical trial; Astronomy; Physics","authors":[{"name":"Toni K. Choueiri","is_ca":false},{"name":"Bernard Escudier","is_ca":false},{"name":"Thomas Powles","is_ca":false},{"name":"Nizar M. Tannir","is_ca":false},{"name":"Paul N. Mainwaring","is_ca":false},{"name":"Brian I. Rini","is_ca":false},{"name":"Hans J. Hammers","is_ca":false},{"name":"Frede Donskov","is_ca":false},{"name":"Bruce J. Roth","is_ca":false},{"name":"Katriina Peltola","is_ca":false},{"name":"Jae‐Lyun Lee","is_ca":false},{"name":"Daniel Y.C. Heng","is_ca":true},{"name":"Manuela Schmidinger","is_ca":false},{"name":"Neeraj Agarwal","is_ca":false},{"name":"Cora N. Sternberg","is_ca":false},{"name":"David F. McDermott","is_ca":false},{"name":"Dana T. Aftab","is_ca":false},{"name":"Colin Hessel","is_ca":false},{"name":"Christian Scheffold","is_ca":false},{"name":"Gisela Schwab","is_ca":false},{"name":"Thomas E. Hutson","is_ca":false},{"name":"Sumanta K. Pal","is_ca":false},{"name":"Robert J. Motzer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1614115617390091,"gpt":0.3921593036737883,"spread":0.2307477419347792,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001338416,0.001174317,0.002918746,0.0002394039,0.0003707508,0.001036112,0.0006039088,0.00119146,0.004178822],"category_scores_gemma":[0.001689906,0.0004156192,0.002136485,0.0003142216,0.0007752244,0.0009912787,0.0003444313,0.002499872,0.0006537524],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007498886,"about_ca_system_score_gemma":0.0008165292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001177505,"about_ca_topic_score_gemma":0.003142987,"domain_scores_codex":[0.9995611,0.0002296394,0.00003077941,0.00006766051,0.00003706295,0.00007375658],"domain_scores_gemma":[0.9992099,0.0002614395,0.0001722863,0.00007070843,0.00004596511,0.0002397197],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9773479,0.001229451,0.0004675315,0.0006258981,0.00116117,0.00004483953,0.00004160876,0.0003314476,0.001707844,0.0001014985,0.0008433459,0.01609761],"study_design_scores_gemma":[0.9617875,0.03370507,0.002027523,0.00004394703,0.0006739856,0.00007396973,0.00002775458,0.0002553422,0.0003007046,0.0002450224,0.0008430615,0.00001614251],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9828363,0.01136041,0.0004693202,0.0009550922,0.0004555176,0.0009866429,0.0009803876,0.0001096746,0.001846723],"genre_scores_gemma":[0.988308,0.004674328,0.001292054,0.0009627148,0.0003696237,0.0009688183,0.001132164,0.00003095436,0.002261424],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004178822,"threshold_uncertainty_score":0.01397955,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}